id,conversation_id,created_at,date,time,timezone,user_id,username,name,place,tweet,language,mentions,urls,photos,replies_count,retweets_count,likes_count,hashtags,cashtags,link,retweet,quote_url,video,thumbnail,near,geo,source,user_rt_id,user_rt,retweet_id,reply_to,retweet_date,translate,trans_src,trans_dest
1206700843426361352,1206700843426361352,2019-12-17 03:51:15 IST,2019-12-17,03:51:15,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$BMY gets the Monday morning kickoff slot formerly owned by $CELG,en,[],[],[],2,5,24,[],"['bmy', 'celg']",https://twitter.com/adamfeuerstein/status/1206700843426361352,False,https://twitter.com/bradloncar/status/1206698516267065346,0,,,,,,,,[],,,,
1203657541617684482,1203657541617684482,2019-12-08 18:18:15 IST,2019-12-08,18:18:15,+0530,873399943,jacobplieth,Jacob Plieth,,If you're invested in the $CELG CVR read my take on yesterday's Transcend-NHL data at #ASH19. Via @Vantageanalysis  https://t.co/gbjESFh3mv $BMY $GILD $NVS,en,"[{'screen_name': 'vantageanalysis', 'name': 'evaluate vantage', 'id': '3033767986'}]",['https://www.evaluate.com/vantage/articles/events/conferences/ash-2019-former-celgene-holders-look-anxiously-contingent-value'],[],2,12,37,['ash19'],"['celg', 'bmy', 'gild', 'nvs']",https://twitter.com/JacobPlieth/status/1203657541617684482,False,,0,,,,,,,,[],,,,
1197635586066173954,1197635586066173954,2019-11-22 03:29:09 IST,2019-11-22,03:29:09,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$BMY CEO Giovanni Caforio speaking to @matthewherper about closing the $CELG merger.   ""Today is Day One‚Ä¶ We started as a new Bristol-Myers Squibb‚Äù  #STATSummit",en,"[{'screen_name': 'matthewherper', 'name': 'matthew herper', 'id': '44438256'}]",[],[],1,3,24,['statsummit'],"['bmy', 'celg']",https://twitter.com/adamfeuerstein/status/1197635586066173954,False,,0,,,,,,,,[],,,,
1197468678167711744,1197468678167711744,2019-11-21 16:25:55 IST,2019-11-21,16:25:55,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$CELG The End.   https://t.co/b4pqLh6xXb  https://t.co/T1OluHWJ1c,en,[],['https://koyfin.com/s/hp6YniMlpk'],['https://pbs.twimg.com/media/EJ5DaovWsAAPrJq.jpg'],8,6,53,[],['celg'],https://twitter.com/adamfeuerstein/status/1197468678167711744,False,,1,https://pbs.twimg.com/media/EJ5DaovWsAAPrJq.jpg,,,,,,,[],,,,
1197264417039278081,1197264417039278081,2019-11-21 02:54:15 IST,2019-11-21,02:54:15,+0530,3043828834,cgrantwsj,Charley Grant,,Bristol-Myers Celgene CVR is about to start trading on NYSE now that deal has closed. Here is my primer from September $BMY $CELG  https://t.co/1zpkyCc68p,en,[],['https://www.wsj.com/articles/a-big-biotech-bet-hiding-in-plain-sight-11569321001'],[],1,6,23,[],"['bmy', 'celg']",https://twitter.com/CGrantWSJ/status/1197264417039278081,False,,0,,,,,,,,[],,,,
1197233495216664576,1197178275250024449,2019-11-21 00:51:23 IST,2019-11-21,00:51:23,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"If you‚Äôre curious. $VRTX Jeff Leiden won Best CEO honors for 2018. $AMRN John Thero finished 2nd. (And yes, I nominated him; Shhhh... don‚Äôt tell those people.)  $CELG Mark Alles was Worst CEO, and soon after, gone w/ Bristol deal.    https://t.co/EG7qhJjPQO",en,[],['https://www.statnews.com/2018/12/18/leiden-victorious-in-best-biopharma-ceo-tally-alles-tops-worst-list/'],[],5,2,20,[],"['vrtx', 'amrn', 'celg']",https://twitter.com/adamfeuerstein/status/1197233495216664576,False,,0,,,,,,,,[],,,,
1196514076400214018,1196514076400214018,2019-11-19 01:12:40 IST,2019-11-19,01:12:40,+0530,991763034304598016,chopraftc,Rohit Chopra,,"From 1995-2015, 60 pharma companies morphed into just 10 giants. The FTC almost never sues to block these deals, and the agency just approved an agreement with @BMSNews &amp; @Celgene that will lead to another massive merger. Here's why I voted no. $BMY $CELG  https://t.co/IvEQxfbivA",en,"[{'screen_name': 'bmsnews', 'name': 'bristol myers squibb', 'id': '34010976'}, {'screen_name': 'celgene', 'name': 'jin', 'id': '1350978062125588490'}]",['https://www.ftc.gov/public-statements/2019/11/dissenting-statement-commissioner-rohit-chopra-matter-bristol-myers-squibb'],[],2,29,49,[],"['bmy', 'celg']",https://twitter.com/chopraftc/status/1196514076400214018,False,,0,,,,,,,,[],,,,
1195710129913651200,1195710129913651200,2019-11-16 19:58:04 IST,2019-11-16,19:58:04,+0530,102754598,johncendpts,John Carroll,,"I started out doing something for the record, but I ended up writing a story with major implications for the industry in 2020 -- FTC clears Bristol-Myers‚Äô $74B deal to buy Celgene ‚Äî but Dems signal a potential hard shift against Big Pharma M&amp;A $BMY $CELG  https://t.co/NCF2c1hKyG",en,[],['https://endpts.com/ftc-clears-bristol-myers-74b-deal-to-buy-celgene-but-dems-signal-a-potential-hard-shift-against-big-pharma-ma/'],[],0,1,8,[],"['bmy', 'celg']",https://twitter.com/JohnCendpts/status/1195710129913651200,False,,0,,,,,,,,[],,,,
1192857291470647299,1192857291470647299,2019-11-08 23:01:55 IST,2019-11-08,23:01:55,+0530,102094857,adamfeuerstein,Adam Feuerstein,,FDA approved $XLRN $CELG luspatercept to treat patients with beta-thalassemia who require red blood cell transfusions. Brand name: Reblozyl,en,[],[],[],4,5,34,[],"['xlrn', 'celg']",https://twitter.com/adamfeuerstein/status/1192857291470647299,False,,0,,,,,,,,[],,,,
1192569874171617281,1192569874171617281,2019-11-08 03:59:49 IST,2019-11-08,03:59:49,+0530,368158573,rebeccadrobbins,Rebecca Robbins,,"The latest episode of @statnews' podcast is up! We discuss: üß† an Alzheimer's approval in China, ft. @Dereklowe üê† $AMRN's Vascepa adcom üìà #ASH19 &amp; $CELG's CAR-T  üéÇ @statnews turns 4, ft. @rickberke  https://t.co/aKqh3GXSyE",en,"[{'screen_name': 'statnews', 'name': 'stat', 'id': '3290364847'}, {'screen_name': 'dereklowe', 'name': 'derek lowe', 'id': '17393219'}, {'screen_name': 'statnews', 'name': 'stat', 'id': '3290364847'}, {'screen_name': 'rickberke', 'name': 'rick berke', 'id': '327449246'}]",['https://www.statnews.com/2019/11/07/podcast-alzheimers-blockbuster-fish-oil-stat-birthday/'],[],1,7,8,['ash19'],"['amrn', 'celg']",https://twitter.com/RebeccaDRobbins/status/1192569874171617281,False,,0,,,,,,,,[],,,,
1192476204084973569,875004688369954816,2019-11-07 21:47:36 IST,2019-11-07,21:47:36,+0530,873399943,jacobplieth,Jacob Plieth,,~8% manufacturing failure rate for JCAR017 seems broadly in line with those Kymriah data from 2017 cc @cells_nnm $CELG $NVS $GILD #ASH19  https://t.co/enzWhmpZgH,en,"[{'screen_name': 'cells_nnm', 'name': 'alexey bersenev', 'id': '14063950'}]",[],['https://pbs.twimg.com/media/EIyGvb9WoAIyyoY.jpg'],1,4,11,['ash19'],"['celg', 'nvs', 'gild']",https://twitter.com/JacobPlieth/status/1192476204084973569,False,,1,https://pbs.twimg.com/media/EIyGvb9WoAIyyoY.jpg,,,,,,,[],,,,
1192463682648694785,1192463682648694785,2019-11-07 20:57:51 IST,2019-11-07,20:57:51,+0530,368158573,rebeccadrobbins,Rebecca Robbins,,"Just finished recording the latest episode of @statnews' podcast. We discuss: üß† an Alzheimer's approval in China, ft. @Dereklowe    üê† $AMRN's Vascepa adcom üìà #ASH19 &amp; $CELG's CAR-T  üéÇ @statnews turns 4, ft. @rickberke  Listen this afternoon:  https://t.co/RiGSuJUYr9",en,"[{'screen_name': 'statnews', 'name': 'stat', 'id': '3290364847'}, {'screen_name': 'dereklowe', 'name': 'derek lowe', 'id': '17393219'}, {'screen_name': 'statnews', 'name': 'stat', 'id': '3290364847'}, {'screen_name': 'rickberke', 'name': 'rick berke', 'id': '327449246'}]",['https://signup.statnews.com/readout-loud'],[],0,5,15,['ash19'],"['amrn', 'celg']",https://twitter.com/RebeccaDRobbins/status/1192463682648694785,False,,0,,,,,,,,[],,,,
1192450854554615809,875741204675219457,2019-11-07 20:06:53 IST,2019-11-07,20:06:53,+0530,873399943,jacobplieth,Jacob Plieth,,Anyone still worry about this kind of detail? (From $CELG JCAR017 #ASH19 abstract.)  https://t.co/CZVirsKJQ8,en,[],[],['https://pbs.twimg.com/media/EIxvsHUX0AEoMrR.jpg'],3,1,4,['ash19'],['celg'],https://twitter.com/JacobPlieth/status/1192450854554615809,False,,1,https://pbs.twimg.com/media/EIxvsHUX0AEoMrR.jpg,,,,,,,[],,,,
1192141864310317056,1192141864310317056,2019-11-06 23:39:04 IST,2019-11-06,23:39:04,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"My pal @BrianSkorney praises $CELG bispecific antibody CC93269 in multiple myeloma, confirming what I also thought looked like very interesting #ASH19 abstract results. This is not a drug talked about much during $BMY merger mania.",en,"[{'screen_name': 'brianskorney', 'name': 'brian skorney', 'id': '285598594'}]",[],[],1,1,13,['ash19'],"['celg', 'bmy']",https://twitter.com/adamfeuerstein/status/1192141864310317056,False,,0,,,,,,,,[],,,,
1192085488951332865,1118521562641108992,2019-11-06 19:55:03 IST,2019-11-06,19:55:03,+0530,873399943,jacobplieth,Jacob Plieth,,So barring a further update at #ASH19 these are the JCAR017 data $CELG $BMY will take to the FDA by the end of the year  https://t.co/7gbrB85zqk,en,[],[],"['https://pbs.twimg.com/media/EIsjZsMWwAQwt3D.jpg', 'https://pbs.twimg.com/media/EIsjarzXsAAMYUf.jpg']",3,5,13,['ash19'],"['celg', 'bmy']",https://twitter.com/JacobPlieth/status/1192085488951332865,False,,1,https://pbs.twimg.com/media/EIsjZsMWwAQwt3D.jpg,,,,,,,[],,,,
1192080498992074753,1192080498992074753,2019-11-06 19:35:13 IST,2019-11-06,19:35:13,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"#ASH19 preview: Celgene, Bluebird, and J&amp;J out with early but telling data in blood cancer  https://t.co/GdkRjSgtAF $CELG $BMY $BLUE $JNJ I had embargoed access to abstracts, including liso-cel TRANSCEND NHL study results. Check it out.",en,[],['https://www.statnews.com/2019/11/06/ash-preview-celgene-bluebird-jnj-blood-cancer/'],[],2,18,44,['ash19'],"['celg', 'bmy', 'blue', 'jnj']",https://twitter.com/adamfeuerstein/status/1192080498992074753,False,,0,,,,,,,,[],,,,
1189895497806483456,1189895497806483456,2019-10-31 18:52:48 IST,2019-10-31,18:52:48,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$CELG, in Q3 earnings release, says bb2121 ph3 results expected by year end. That‚Äôs the BCMA-targeted CAR-T developed in partnership with $BLUE. Sounds like this will be a top-line PR and not an #ASH19 presentation.",en,[],[],[],1,6,6,['ash19'],"['celg', 'blue']",https://twitter.com/adamfeuerstein/status/1189895497806483456,False,,0,,,,,,,,[],,,,
1176446020596711425,1176446020596711425,2019-09-24 16:09:23 IST,2019-09-24,16:09:23,+0530,3043828834,cgrantwsj,Charley Grant,,"If you‚Äôre in the mood to make 4x your money or lose the whole thing in the next 18 months, you should know about this wrinkle in the $BMY $CELG deal  https://t.co/tMTpZQUWDD",en,[],['https://www.wsj.com/articles/a-big-biotech-bet-hiding-in-plain-sight-11569321001?mod=djemheard_t'],[],4,7,34,[],"['bmy', 'celg']",https://twitter.com/CGrantWSJ/status/1176446020596711425,False,,0,,,,,,,,[],,,,
1173613990972444672,1172904208942739456,2019-09-16 20:35:54 IST,2019-09-16,20:35:54,+0530,1413027896,charliebilello,Charlie Bilello,,"Best Performing S&amp;P 500 stocks, last 20 yrs... Monster Beverage $MNST: +72,340% Tractor Supply $TSCO: +33,500% Cognizant Tech $CTSH: +14,150% HollyFrontier $HFC: +10,560% Ventas $VTR: +9,520% Apple $AAPL: +9,260% NVIDIA $NVDA: +9,140% Celgene $CELG: +8,880% Ansys $ANSS: +8,830%",en,[],[],[],6,46,176,[],"['mnst', 'tsco', 'ctsh', 'hfc', 'vtr', 'aapl', 'nvda', 'celg', 'anss']",https://twitter.com/charliebilello/status/1173613990972444672,False,,0,,,,,,,,[],,,,
1172178057064603650,1172178057064603650,2019-09-12 21:30:01 IST,2019-09-12,21:30:01,+0530,20119344,greenbackd,Tobias Carlisle,,George Soros's 6-30-2019 portfolio (value $4.3bb)  Top 10 Holdings  1 $LBRDK / Liberty Broadband $757mm 2 $VICI / Vici Properties   $453mm 3 $CZR / Caesars Entertainment $225mm 4 $QQQ $218mm 5 $AABA / Altaba $171mm 6 $RHT / Red Hat $97mm 7 $CELG / Celgene Corp $76mm 8 ...,und,[],[],[],1,6,18,[],"['lbrdk', 'vici', 'czr', 'qqq', 'aaba', 'rht', 'celg']",https://twitter.com/Greenbackd/status/1172178057064603650,False,https://twitter.com/acquirersx/status/1172085483989557249,0,,,,,,,,[],,,,
1166719178843336705,1166719178843336705,2019-08-28 19:58:23 IST,2019-08-28,19:58:23,+0530,873399943,jacobplieth,Jacob Plieth,,You thought engineered TCRs were dead? Think again! 2 deals in 2 days. Via @ByAmyBrown  https://t.co/V2ICPHhNEy $CELG $ADAP $BLCM $GSK $BLUE,en,"[{'screen_name': 'byamybrown', 'name': 'amy brown', 'id': '1280320154'}]",['http://bit.ly/2LgxmrU'],[],2,9,20,[],"['celg', 'adap', 'blcm', 'gsk', 'blue']",https://twitter.com/JacobPlieth/status/1166719178843336705,False,,0,,,,,,,,[],,,,
1166360766200647681,1166066334393937921,2019-08-27 20:14:11 IST,2019-08-27,20:14:11,+0530,873399943,jacobplieth,Jacob Plieth,,"@evaluatepharma Six burning questions after the Otezla win-win-win, via @Vantageanalysis  https://t.co/cN7Ocz8Xha $CELG $BMY $AMGN",en,"[{'screen_name': 'vantageanalysis', 'name': 'evaluate vantage', 'id': '3033767986'}]",['https://www.evaluate.com/vantage/articles/analysis/six-burning-otezla-questions'],[],1,15,9,[],"['celg', 'bmy', 'amgn']",https://twitter.com/JacobPlieth/status/1166360766200647681,False,,0,,,,,,,,"[{'screen_name': 'evaluatepharma', 'name': 'Evaluate Pharma', 'id': '43901066'}]",,,,
1166066334393937921,1166066334393937921,2019-08-27 00:44:13 IST,2019-08-27,00:44:13,+0530,873399943,jacobplieth,Jacob Plieth,,Based on sellside consensus Otezla NPV was $9.6bn. Via @evaluatepharma $AMGN $BMY $CELG  https://t.co/U7WravszkY,en,"[{'screen_name': 'evaluatepharma', 'name': 'evaluate pharma', 'id': '43901066'}]",[],"['https://pbs.twimg.com/media/EC6zJZLXYAAplzI.jpg', 'https://pbs.twimg.com/media/EC6zJaXXsAAkf6D.jpg']",1,0,7,[],"['amgn', 'bmy', 'celg']",https://twitter.com/JacobPlieth/status/1166066334393937921,False,,1,https://pbs.twimg.com/media/EC6zJZLXYAAplzI.jpg,,,,,,,[],,,,
1165944167329075201,1165944167329075201,2019-08-26 16:38:46 IST,2019-08-26,16:38:46,+0530,102754598,johncendpts,John Carroll,,BREAKING: Amgen swoops in with $13.4B deal to pluck blockbuster Otezla from Celgene $AMGN $CELG $BMY  https://t.co/HXmDDWjsgx,en,[],['https://endpts.com/breaking-amgen-swoops-in-with-13-4b-deal-to-pluck-blockbuster-otezla-from-celgene/'],[],0,6,12,[],"['amgn', 'celg', 'bmy']",https://twitter.com/JohnCendpts/status/1165944167329075201,False,,0,,,,,,,,[],,,,
1165937270060408832,1165937270060408832,2019-08-26 16:11:21 IST,2019-08-26,16:11:21,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$AMGN was on just about everyone‚Äôs list of interested bidders for the $CELG $BMY drug Otezla. The $13.4 billion purchase price is higher than expected.,en,[],[],[],3,2,19,[],"['amgn', 'celg', 'bmy']",https://twitter.com/adamfeuerstein/status/1165937270060408832,False,,0,,,,,,,,[],,,,
1165934931136192512,1165934931136192512,2019-08-26 16:02:04 IST,2019-08-26,16:02:04,+0530,34010976,bmsnews,Bristol Myers Squibb,,#MEDIA: Announcing divestiture agreement for psoriasis treatment in connection with pending $BMY $CELG merger  https://t.co/ULhOddcbZd  https://t.co/DJvM9Tsn59,en,[],['https://one.bms.com/341o0co'],['https://pbs.twimg.com/media/EC47pB-WkAEf62h.jpg'],0,9,12,['media'],"['bmy', 'celg']",https://twitter.com/bmsnews/status/1165934931136192512,False,,1,https://pbs.twimg.com/media/EC47pB-WkAEf62h.jpg,,,,,,,[],,,,
1162361848274006016,1162361848274006016,2019-08-16 19:23:54 IST,2019-08-16,19:23:54,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$CELG $BMY fedratinib FDA approved label is here:    https://t.co/Jsm0ESuyD6  Brand name: Inrebic,en,[],['https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212327s000lbl.pdf'],[],2,4,14,[],"['celg', 'bmy']",https://twitter.com/adamfeuerstein/status/1162361848274006016,False,,0,,,,,,,,[],,,,
1159443659001122816,931159713542213634,2019-08-08 18:08:04 IST,2019-08-08,18:08:04,+0530,873399943,jacobplieth,Jacob Plieth,,Sounds like $AUTL is effectively discontinuing AUTO2 (BCMA Taci CAR). Insufficiently differentiated vs $BLUE $CELG,en,[],[],[],3,3,7,[],"['autl', 'blue', 'celg']",https://twitter.com/JacobPlieth/status/1159443659001122816,False,,0,,,,,,,,[],,,,
1159086105586802688,1159086105586802688,2019-08-07 18:27:17 IST,2019-08-07,18:27:17,+0530,873399943,jacobplieth,Jacob Plieth,,Note exclusion criteria in $ALLO $CLLS ALLO-715 (anti-BCMA CAR-T) phase 1 study $BLUE $CELG  https://t.co/qYJoLjtQpi,en,[],[],['https://pbs.twimg.com/media/EBXmqvuXYAIo3VJ.jpg'],2,3,5,[],"['allo', 'clls', 'blue', 'celg']",https://twitter.com/JacobPlieth/status/1159086105586802688,False,,1,https://pbs.twimg.com/media/EBXmqvuXYAIo3VJ.jpg,,,,,,,[],,,,
1154007377798193152,1154006624111140864,2019-07-24 18:06:13 IST,2019-07-24,18:06:13,+0530,873399943,jacobplieth,Jacob Plieth,,$JNCE up 30% in the premarket as it takes $CELG a year to figure out that the ICOS project is inert  https://t.co/D7ANC9hK0V,en,[],['http://bit.ly/2JX6MDI'],[],1,3,5,[],"['jnce', 'celg']",https://twitter.com/JacobPlieth/status/1154007377798193152,False,,0,,,,,,,,[],,,,
1147134364289044481,1147134364289044481,2019-07-05 18:55:19 IST,2019-07-05,18:55:19,+0530,3043828834,cgrantwsj,Charley Grant,,Important read if you own $AGN or $CELG,en,[],[],[],1,7,16,[],"['agn', 'celg']",https://twitter.com/CGrantWSJ/status/1147134364289044481,False,https://twitter.com/WSJ/status/1147131776285990912,0,,,,,,,,[],,,,
1143169553360465926,1143169553360465926,2019-06-24 20:20:35 IST,2019-06-24,20:20:35,+0530,873399943,jacobplieth,Jacob Plieth,,FTC increasingly looking at antitrust issues involving pre-launch assets? $BMY $CELG  https://t.co/6eqlFO0NM6,en,[],['https://twitter.com/RobinDavison2/status/1143166779239387141'],[],1,0,7,[],"['bmy', 'celg']",https://twitter.com/JacobPlieth/status/1143169553360465926,False,https://twitter.com/RobinDavison2/status/1143166779239387141,0,,,,,,,,[],,,,
1143112361068441600,1143112361068441600,2019-06-24 16:33:19 IST,2019-06-24,16:33:19,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$BMY is divesting the $CELG psoriasis drug Otezla to satisfy FTC requirements for the closing of the merger.    https://t.co/2y5IFby4T8,en,[],['https://www.businesswire.com/news/home/20190624005294/en/'],[],3,16,15,[],"['bmy', 'celg']",https://twitter.com/adamfeuerstein/status/1143112361068441600,False,,0,,,,,,,,[],,,,
1136227032067690496,1136227032067690496,2019-06-05 16:33:29 IST,2019-06-05,16:33:29,+0530,34010976,bmsnews,Bristol Myers Squibb,,#MEDIA: This morning we announced our post-closing Leadership Team  https://t.co/Ne6E0fFD1R $BMY $CELG  https://t.co/KjRSjHWK0S,en,[],['https://one.bms.com/2HUe1wi'],['https://pbs.twimg.com/media/D8SwdriXUAIkvrv.jpg'],0,12,14,['media'],"['bmy', 'celg']",https://twitter.com/bmsnews/status/1136227032067690496,False,,1,https://pbs.twimg.com/media/D8SwdriXUAIkvrv.jpg,,,,,,,[],,,,
1129382633371312128,1129382633371312128,2019-05-17 19:16:17 IST,2019-05-17,19:16:17,+0530,16838276,philstockworld,Phil Davis,,"Faltering Friday - Markets Give Up Half the ""Rally"" on Bad Trade News $SPY $AAPL $CELG $DIS $CAT #Hedging $UGA #PortfolioManagement --    https://t.co/pNsJyvoktg  https://t.co/PWMqLMJID9",en,[],['https://www.philstockworld.com/2019/05/17/faltering-friday-markets-give-up-half-the-rally-on-no-news/'],['https://pbs.twimg.com/media/D6xfgk-XoAAmezi.jpg'],1,1,15,"['hedging', 'portfoliomanagement']","['spy', 'aapl', 'celg', 'dis', 'cat', 'uga']",https://twitter.com/philstockworld/status/1129382633371312128,False,,1,https://pbs.twimg.com/media/D6xfgk-XoAAmezi.jpg,,,,,,,[],,,,
1122844514081808385,1122844514081808385,2019-04-29 18:16:08 IST,2019-04-29,18:16:08,+0530,14886375,stocktwits,Stocktwits,,EARNINGS THIS WEEK  Mon $GOOG $SPOT Tue $AAPL $AMD $GE $SHOP  Wed $SQ $AMRN $QCOM  Thu $GILD $ATVI Fri $CELG $WYNN   https://t.co/wiZyO71Kyg,en,[],['https://www.stocktwits.com/discover/earnings-calendar'],[],3,20,33,[],"['goog', 'spot', 'aapl', 'amd', 'ge', 'shop', 'sq', 'amrn', 'qcom', 'gild', 'atvi', 'celg', 'wynn']",https://twitter.com/Stocktwits/status/1122844514081808385,False,,0,,,,,,,,[],,,,
1121422971661426688,1121422971661426688,2019-04-25 20:07:26 IST,2019-04-25,20:07:26,+0530,873399943,jacobplieth,Jacob Plieth,,Listening to $BMY Q1 call: first time I've heard Giovanni Caforio virtually admit that $CELG move was driven by concern about Eliquis &amp; Opdivo long term,en,[],[],[],3,3,17,[],"['bmy', 'celg']",https://twitter.com/JacobPlieth/status/1121422971661426688,False,,0,,,,,,,,[],,,,
1118852565947572224,1118852565947572224,2019-04-18 17:53:33 IST,2019-04-18,17:53:33,+0530,873399943,jacobplieth,Jacob Plieth,,"A few hints in the #ASCO19 titles, via @Vantageanalysis $MRKR $CELG $BMY $AMGN $MRTX  https://t.co/CupBxF2Ms7",en,"[{'screen_name': 'vantageanalysis', 'name': 'evaluate vantage', 'id': '3033767986'}]",['http://bit.ly/2v7nI3s'],[],1,4,21,['asco19'],"['mrkr', 'celg', 'bmy', 'amgn', 'mrtx']",https://twitter.com/JacobPlieth/status/1118852565947572224,False,,0,,,,,,,,[],,,,
1116847052988854273,1116847052988854273,2019-04-13 05:04:22 IST,2019-04-13,05:04:22,+0530,34010976,bmsnews,Bristol Myers Squibb,,Our Chairman and CEO Giovanni Caforio appeared today on @MadMoneyOnCNBC with @jimcramer to discuss today‚Äôs positive shareholder vote supporting the company‚Äôs $CELG transaction.,en,"[{'screen_name': 'madmoneyoncnbc', 'name': 'mad money on cnbc', 'id': '16451932'}, {'screen_name': 'jimcramer', 'name': 'jim cramer', 'id': '14216123'}]",[],[],0,4,16,[],['celg'],https://twitter.com/bmsnews/status/1116847052988854273,False,,0,,,,,,,,[],,,,
1116764995893616640,1116764995893616640,2019-04-12 23:38:18 IST,2019-04-12,23:38:18,+0530,44438256,matthewherper,Matthew Herper,,Here's my goodbye to $CELG story from January. Looking forward to covering the new $BMY.  https://t.co/JxsOqBmk1x,en,[],['https://www.statnews.com/2019/01/22/celgene-legacy-chutzpah-science-drug-pricing/'],[],0,3,7,[],"['celg', 'bmy']",https://twitter.com/matthewherper/status/1116764995893616640,False,,0,,,,,,,,[],,,,
1116757691253362688,1116757691253362688,2019-04-12 23:09:16 IST,2019-04-12,23:09:16,+0530,274233761,bradloncar,Brad Loncar,,"""At the same time, I do not minimize the fact that some shareholders had expressed concerns about the deal."" - Giovani Caforio  GC is a classy, good guy. I still think this merger is a bad idea, but it's over now so wishing him and both companies the best. $BMY $CELG",en,[],[],[],2,2,5,[],"['bmy', 'celg']",https://twitter.com/bradloncar/status/1116757691253362688,False,https://twitter.com/JaredSHopkins/status/1116743209869348865,0,,,,,,,,[],,,,
1116747932160729090,1116747932160729090,2019-04-12 22:30:29 IST,2019-04-12,22:30:29,+0530,102094857,adamfeuerstein,Adam Feuerstein,,RBC‚Äôs Brian Abrahams on $CELG:   ‚ÄúAlles Well That Ends Well.‚Äù,en,[],[],[],2,1,12,[],['celg'],https://twitter.com/adamfeuerstein/status/1116747932160729090,False,,0,,,,,,,,[],,,,
1116715342678638592,1116715342678638592,2019-04-12 20:20:59 IST,2019-04-12,20:20:59,+0530,34010976,bmsnews,Bristol Myers Squibb,,$BMY shareholders approve $CELG transaction.,en,[],[],[],2,19,43,[],"['bmy', 'celg']",https://twitter.com/bmsnews/status/1116715342678638592,False,,0,,,,,,,,[],,,,
1116710136196866049,1116710136196866049,2019-04-12 20:00:18 IST,2019-04-12,20:00:18,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"The Bristol-Celgene merger is approved. Here are 8 challenges ahead  https://t.co/bmQtS471fV  $BMY $CELG (say goodbye to that ticker) By @damiangarde and yours truly. Plus, another great illustration from @HoganAlex",en,"[{'screen_name': 'damiangarde', 'name': 'damian garde', 'id': '529704495'}, {'screen_name': 'hoganalex', 'name': 'alex hogan', 'id': '296572811'}]",['https://www.statnews.com/2019/04/12/bristol-myers-squibb-celgene-challenges-ahead/'],[],4,7,17,[],"['bmy', 'celg']",https://twitter.com/adamfeuerstein/status/1116710136196866049,False,,0,,,,,,,,[],,,,
1116709492878606337,1116709492878606337,2019-04-12 19:57:45 IST,2019-04-12,19:57:45,+0530,15281391,thestreet,TheStreet,,BREAKING: Bristol-Myers $BMY shareholders vote to approve Celgene $CELG deal.,en,[],[],[],0,3,4,[],"['bmy', 'celg']",https://twitter.com/TheStreet/status/1116709492878606337,False,,0,,,,,,,,[],,,,
1113776148696240136,1113776148696240136,2019-04-04 17:41:41 IST,2019-04-04,17:41:41,+0530,102754598,johncendpts,John Carroll,,"Eyeing a fast pitch for quick OK in race with bluebird, J&amp;J/Legend team enjoys a regulatory embrace for their rival BCMA CAR-T (Prime based in part on new data) $JNJ $BLUE $CELG $BMY  https://t.co/AWFJNBVOVi",en,[],['https://endpts.com/eyeing-a-fast-pitch-for-quick-ok-in-race-with-bluebird-jj-legend-team-enjoys-a-regulatory-embrace-for-their-rival-bcma-car-t/'],[],0,3,5,[],"['jnj', 'blue', 'celg', 'bmy']",https://twitter.com/JohnCendpts/status/1113776148696240136,False,,0,,,,,,,,[],,,,
1113541090223718401,1113541090223718401,2019-04-04 02:07:39 IST,2019-04-04,02:07:39,+0530,102754598,johncendpts,John Carroll,,And #9 with a bullet -- Biotech billionaire faces accusations of fraud for $1.3B ‚Äòcatch-and-kill‚Äô cancer drug deal $CELG  https://t.co/WwIDzmZSqG,en,[],['https://endpts.com/biotech-billionaire-faces-fresh-accusations-of-fraud-for-1-3b-catch-and-kill-cancer-drug-deal/'],[],2,7,9,[],['celg'],https://twitter.com/JohnCendpts/status/1113541090223718401,False,,0,,,,,,,,[],,,,
1113517275456442368,1113517275456442368,2019-04-04 00:33:01 IST,2019-04-04,00:33:01,+0530,102754598,johncendpts,John Carroll,,"To be fair, I actually did get a response from $CELG this time. ""No comment""  https://t.co/WwIDzmZSqG",en,[],['https://endpts.com/biotech-billionaire-faces-fresh-accusations-of-fraud-for-1-3b-catch-and-kill-cancer-drug-deal/'],[],1,4,8,[],['celg'],https://twitter.com/JohnCendpts/status/1113517275456442368,False,,0,,,,,,,,[],,,,
1113506463085993984,1113506463085993984,2019-04-03 23:50:03 IST,2019-04-03,23:50:03,+0530,102754598,johncendpts,John Carroll,,"So for the record, I did ask representatives of Soon-Shiong and $CELG for a comment. Celgene's entire media group evidently went on a sabbatical about a year ago. Speaks volumes, doesn't it?  https://t.co/WwIDzmZSqG",en,[],['https://endpts.com/biotech-billionaire-faces-fresh-accusations-of-fraud-for-1-3b-catch-and-kill-cancer-drug-deal/'],[],0,8,26,[],['celg'],https://twitter.com/JohnCendpts/status/1113506463085993984,False,,0,,,,,,,,[],,,,
1111671779532173312,1111671779532173312,2019-03-29 22:19:40 IST,2019-03-29,22:19:40,+0530,102094857,adamfeuerstein,Adam Feuerstein,,That feeling when you arb‚Äôd the $BMY $CELG deal and read the ISS and Glass Lewis reports.  https://t.co/9EGA0CUf9G,en,[],[],['https://pbs.twimg.com/tweet_video_thumb/D21zi6-X4AIMCFC.jpg'],0,0,15,[],"['bmy', 'celg']",https://twitter.com/adamfeuerstein/status/1111671779532173312,False,,1,https://pbs.twimg.com/tweet_video_thumb/D21zi6-X4AIMCFC.jpg,,,,,,,[],,,,
1111635244439007234,1111635244439007234,2019-03-29 19:54:30 IST,2019-03-29,19:54:30,+0530,102754598,johncendpts,John Carroll,,Analysts saying the $CELG deal is all but done now --  https://t.co/Xg8eVsu20D,en,[],['https://endpts.com/celgene-shares-pop-as-bristol-myers-gains-key-support-from-proxy-adviser-for-looming-buyout-vote/'],[],1,6,8,[],['celg'],https://twitter.com/JohnCendpts/status/1111635244439007234,False,,0,,,,,,,,[],,,,
1110999796863696896,1110999796863696896,2019-03-28 01:49:27 IST,2019-03-28,01:49:27,+0530,15568127,themotleyfool,The Motley Fool,,"So many great topics on today's @MFIndustryFocus show: Biogen's big pipeline blow up, the latest gene therapy M&amp;A news, and updates on the Bristol-Myers Squibb &amp; Celgene drama.  Subscribe wherever you get podcasts and Fool On! $BIIB $BMY $CELG $TMO  https://t.co/o8VtfPSle3",en,"[{'screen_name': 'mfindustryfocus', 'name': 'industry focus', 'id': '1548736957'}]",[],[],0,2,10,[],"['biib', 'bmy', 'celg', 'tmo']",https://twitter.com/themotleyfool/status/1110999796863696896,False,,1,https://pbs.twimg.com/ext_tw_video_thumb/1110999508685602819/pu/img/0auPrhFekyIaNXr2.jpg,,,,,,,[],,,,
1110686957074558981,1110686957074558981,2019-03-27 05:06:20 IST,2019-03-27,05:06:20,+0530,102754598,johncendpts,John Carroll,,and there we go... Blockbuster to be? Novartis snags a major win as FDA OKs one of its top 3 late-stage drugs $NVS $CELG $BMY  https://t.co/su9GDfaonC,en,[],['https://endpts.com/blockbuster-to-be-novartis-snags-a-major-win-as-fda-oks-one-of-its-top-3-late-stage-drugs/'],[],2,2,10,[],"['nvs', 'celg', 'bmy']",https://twitter.com/JohnCendpts/status/1110686957074558981,False,,0,,,,,,,,[],,,,
1110491480043520001,1110491480043520001,2019-03-26 16:09:35 IST,2019-03-26,16:09:35,+0530,102754598,johncendpts,John Carroll,,"Buyout vote looming, Celgene files for ozanimod OK (again), with a multibillion-dollar bet riding on every step $CELG $BMY  https://t.co/G01MZ18DG2",en,[],['https://endpts.com/biotech-on-a-wire-celgene-files-for-ozanimod-ok-again-with-a-multibillion-dollar-bet-riding-on-every-step/'],[],2,3,4,[],"['celg', 'bmy']",https://twitter.com/JohnCendpts/status/1110491480043520001,False,,0,,,,,,,,[],,,,
1109195854487928833,1109195854487928833,2019-03-23 02:21:14 IST,2019-03-23,02:21:14,+0530,102754598,johncendpts,John Carroll,,Once again reminded today that $BIIB has the only PR arm that is worse than $CELG 's . Is this a coincidence? I don't think so.,en,[],[],[],0,1,8,[],"['biib', 'celg']",https://twitter.com/JohnCendpts/status/1109195854487928833,False,,0,,,,,,,,[],,,,
1108706764596432896,1108706764596432896,2019-03-21 17:57:46 IST,2019-03-21,17:57:46,+0530,102754598,johncendpts,John Carroll,,"Death of the amyloid beta theory, a reckoning for $BIIB, $CELG style, and more -- analysts look to what comes next after the big aducanumab flop.  https://t.co/v7bNdlJSAR",en,[],['https://endpts.com/biogens-alzheimers-drug-aducanumab-implodes-in-a-phiii-disaster/'],[],2,2,10,[],"['biib', 'celg']",https://twitter.com/JohnCendpts/status/1108706764596432896,False,,0,,,,,,,,[],,,,
1108031986659143680,1108031986659143680,2019-03-19 21:16:26 IST,2019-03-19,21:16:26,+0530,3043828834,cgrantwsj,Charley Grant,,Starboard Value has an interesting take on how past mega mergers in pharma have worked out $BMY $CELG $MRK  https://t.co/WJi3yu7es8,en,[],['https://www.wsj.com/articles/if-this-is-failure-show-me-success-11553008893'],[],1,3,9,[],"['bmy', 'celg', 'mrk']",https://twitter.com/CGrantWSJ/status/1108031986659143680,False,,0,,,,,,,,[],,,,
1105427101321252866,1105427101321252866,2019-03-12 16:45:33 IST,2019-03-12,16:45:33,+0530,3043828834,cgrantwsj,Charley Grant,,"If your fund owns $BMY and not $CELG (or are underweight it), you are significantly underperforming your benchmark if this deal goes ahead.",en,[],[],[],2,1,9,[],"['bmy', 'celg']",https://twitter.com/CGrantWSJ/status/1105427101321252866,False,,0,,,,,,,,[],,,,
1105108207343685634,1105108207343685634,2019-03-11 19:38:23 IST,2019-03-11,19:38:23,+0530,44438256,matthewherper,Matthew Herper,,"This @benthefidler profile of George Golumbeski, formerly $CELG's big dealmaker, now of ARCH and Grail, is simply fantastic. Among the details: Golumbeski's personal battle with depression and $NVS almost bought $CELG in the early 2000s.  https://t.co/y06FbH5QKy",en,"[{'screen_name': 'benthefidler', 'name': 'ben fidler', 'id': '1330055544'}]",['https://xconomy.com/national/2019/03/11/the-life-troubles-and-celgene-legacy-of-deal-guru-george-golumbeski/'],[],1,8,41,[],"['celg', 'nvs', 'celg']",https://twitter.com/matthewherper/status/1105108207343685634,False,,0,,,,,,,,[],,,,
1103410298353057792,1103410298353057792,2019-03-07 03:11:30 IST,2019-03-07,03:11:30,+0530,102754598,johncendpts,John Carroll,,You think $BMY is running a tad scared? I heard back from their PR arm within minutes of running this: Another influential voice takes Bristol-Myers‚Äô top execs to task as they scramble to shore up the big Celgene buyout $BMY $CELG  https://t.co/heWlyhTAdt,en,[],['https://endpts.com/another-influential-voice-takes-bristol-myers-top-execs-to-task-as-they-scramble-to-shore-up-the-big-celgene-buyout/'],[],4,11,30,[],"['bmy', 'bmy', 'celg']",https://twitter.com/JohnCendpts/status/1103410298353057792,False,,0,,,,,,,,[],,,,
1103306140828532738,1103306140828532738,2019-03-06 20:17:37 IST,2019-03-06,20:17:37,+0530,873399943,jacobplieth,Jacob Plieth,,The nicest guy on biotwitter just came out against $BMY $CELG,en,[],[],[],4,1,14,[],"['bmy', 'celg']",https://twitter.com/JacobPlieth/status/1103306140828532738,False,,0,,,,,,,,[],,,,
1103272305843683328,1103272305843683328,2019-03-06 18:03:10 IST,2019-03-06,18:03:10,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Dueling letters‚Ä¶  $BMY $CELG   https://t.co/XTSG9OtJWa   https://t.co/yvrcstN8OO,en,[],"['https://shareholdersforbristol.com/', 'https://bestofbiopharma.com/']",[],2,3,9,[],"['bmy', 'celg']",https://twitter.com/adamfeuerstein/status/1103272305843683328,False,,0,,,,,,,,[],,,,
1102615998207791104,1102615998207791104,2019-03-04 22:35:14 IST,2019-03-04,22:35:14,+0530,3043828834,cgrantwsj,Charley Grant,,My spin on the pharma megamerger roulette wheel $CELG $BMY  https://t.co/eiZwLRboJj,en,[],['https://www.wsj.com/articles/celgene-odds-are-in-investors-favor-11551718821'],[],1,5,10,[],"['celg', 'bmy']",https://twitter.com/CGrantWSJ/status/1102615998207791104,False,,0,,,,,,,,[],,,,
1101194892146106368,1101194892146106368,2019-03-01 00:28:16 IST,2019-03-01,00:28:16,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Suddenly, the Bristol-Celgene deal is looking shaky. What might be next for Celgene?  https://t.co/LXN5a1pkK3 $CELG $BMY and another biotech ticker, but you need to read. h/t to @alissa_ambrose and @hoganalex for the wicked-cool illustration.",en,"[{'screen_name': 'alissa_ambrose', 'name': 'alissa ambrose', 'id': '198514721'}, {'screen_name': 'hoganalex', 'name': 'alex hogan', 'id': '296572811'}]",['https://www.statnews.com/2019/02/28/bristol-celgene-deal-shaky-celgene/'],[],5,3,16,[],"['celg', 'bmy']",https://twitter.com/adamfeuerstein/status/1101194892146106368,False,,0,,,,,,,,[],,,,
1101139218015965188,1101139218015965188,2019-02-28 20:47:02 IST,2019-02-28,20:47:02,+0530,102754598,johncendpts,John Carroll,,"Starboard has been preparing the full investor case against the deal. Slams both $BMY and $CELG - which has struggled. Wants, basically, for someone to buy $BMY",en,[],[],[],0,6,5,[],"['bmy', 'celg', 'bmy']",https://twitter.com/JohnCendpts/status/1101139218015965188,False,https://twitter.com/ATLanalyst/status/1101132775799877632,0,,,,,,,,[],,,,
1100914726387834880,1100914726387834880,2019-02-28 05:54:59 IST,2019-02-28,05:54:59,+0530,102754598,johncendpts,John Carroll,,Is the $74B $CELG buyout deal that fragile? $CELG -10.4% $BMY up 2.6% on news that $BMY 's largest shareholder openly opposed the deal.  https://t.co/pjMPvFd5eO,en,[],['https://endpts.com/bristol-myers-largest-shareholder-comes-out-against-its-74b-celgene-buyout-raising-a-real-risk-of-torpedoing-the-deal/'],[],5,16,22,[],"['celg', 'celg', 'bmy', 'bmy']",https://twitter.com/JohnCendpts/status/1100914726387834880,False,,0,,,,,,,,[],,,,
1100906560379932674,1100906560379932674,2019-02-28 05:22:32 IST,2019-02-28,05:22:32,+0530,3203314919,cararlombardo,Cara Lombardo,,This comes after @WSJ reported last week that other significant shareholders including Starboard and Dodge &amp; Cox are also unhappy with the deal $BMY $CELG,en,"[{'screen_name': 'wsj', 'name': 'the wall street journal', 'id': '3108351'}]",[],[],0,2,5,[],"['bmy', 'celg']",https://twitter.com/CaraRLombardo/status/1100906560379932674,False,https://twitter.com/PatThomas1318/status/1100904621210591233,0,,,,,,,,[],,,,
1100898211097645056,1100898211097645056,2019-02-28 04:49:21 IST,2019-02-28,04:49:21,+0530,102754598,johncendpts,John Carroll,,"Uh-oh Bristol-Myers‚Äô largest shareholder comes out against its $74B Celgene buyout, raising a ‚Äòreal risk‚Äô of torpedoing the deal $BMY $CELG  https://t.co/pjMPvFd5eO",en,[],['https://endpts.com/bristol-myers-largest-shareholder-comes-out-against-its-74b-celgene-buyout-raising-a-real-risk-of-torpedoing-the-deal/'],[],3,8,16,[],"['bmy', 'celg']",https://twitter.com/JohnCendpts/status/1100898211097645056,False,,0,,,,,,,,[],,,,
1100893202314395648,1100893202314395648,2019-02-28 04:29:27 IST,2019-02-28,04:29:27,+0530,292876633,kristen_hallam,Kristen Hallam,,BREAKING: Bristol-Myers' largest shareholder Wellington rejects $95B Celgene deal $BMY $CELG  https://t.co/gouDXwacax,en,[],['https://www.spglobal.com/marketintelligence/en/news-insights/trending/9w9_lhzkz25PmwDfpW1Irw2'],[],0,10,8,[],"['bmy', 'celg']",https://twitter.com/kristen_hallam/status/1100893202314395648,False,,0,,,,,,,,[],,,,
1100873490121527306,1100873490121527306,2019-02-28 03:11:07 IST,2019-02-28,03:11:07,+0530,15281391,thestreet,TheStreet,,Celgene $CELG falling more than 5% after Wellington says it doesn't back Bristol-Myers $BMY deal,en,[],[],[],0,2,5,[],"['celg', 'bmy']",https://twitter.com/TheStreet/status/1100873490121527306,False,,0,,,,,,,,[],,,,
1100870484340678656,1100870484340678656,2019-02-28 02:59:11 IST,2019-02-28,02:59:11,+0530,274233761,bradloncar,Brad Loncar,,I agree with Wellington on this Bristol-Celgene acquisition. Very hard to support it if you are on the Bristol side. Bristol management hasn't earned it. $BMY $CELG,en,[],[],[],5,3,27,[],"['bmy', 'celg']",https://twitter.com/bradloncar/status/1100870484340678656,False,,0,,,,,,,,[],,,,
1100438716710113280,1100438716710113280,2019-02-26 22:23:29 IST,2019-02-26,22:23:29,+0530,44438256,matthewherper,Matthew Herper,,"Odd to imagine what this moment, when Menendez is questioning these CEOs, would be like if Robert Hugin, formerly of $CELG, had won instead. #drugprices",en,[],[],[],3,2,23,['drugprices'],['celg'],https://twitter.com/matthewherper/status/1100438716710113280,False,,0,,,,,,,,[],,,,
1096427815048830976,1096427815048830976,2019-02-15 20:45:36 IST,2019-02-15,20:45:36,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Mizuho analyst Salim Syed put together an 80-slide deck to ponder the question: Will $AMGN bid for $BMY and break up the $CELG deal?   80 slides! That‚Äôs a lot of work for his junior analysts. I hope they got some breaks.   Salim‚Äôs conclusion: No. Oh‚Ä¶,en,[],[],[],13,4,39,[],"['amgn', 'bmy', 'celg']",https://twitter.com/adamfeuerstein/status/1096427815048830976,False,,0,,,,,,,,[],,,,
1095811862980104193,1095811862980104193,2019-02-14 03:58:01 IST,2019-02-14,03:58:01,+0530,274233761,bradloncar,Brad Loncar,,"In regards to the generic Revlimid news today, per Credit Suisse and others $CELG licensed the drug to Alvogen for these countries so it's a non-event.",en,[],[],[],1,4,22,[],['celg'],https://twitter.com/bradloncar/status/1095811862980104193,False,,0,,,,,,,,[],,,,
1092410658510065669,1092410658510065669,2019-02-04 18:42:51 IST,2019-02-04,18:42:51,+0530,102754598,johncendpts,John Carroll,,‚ÄòMost feared‚Äô activist investor in America has zeroed in on Bristol-Myers Squibb. Is he planning to derail the $74B Celgene buyout? $BMY $CELG -2.25%  https://t.co/pksWNxLG72,en,[],['https://endpts.com/most-feared-activist-investor-in-america-has-zeroed-in-on-bristol-myers-squibb-is-he-planning-to-derail-the-74b-celgene-buyout/'],[],1,9,17,[],"['bmy', 'celg']",https://twitter.com/JohnCendpts/status/1092410658510065669,False,,0,,,,,,,,[],,,,
1091343432377880576,1091343432377880576,2019-02-01 20:02:05 IST,2019-02-01,20:02:05,+0530,102754598,johncendpts,John Carroll,,"Playing hardball, Bristol-Myers bought out a battered Celgene with last-minute terms sweetened in its favor $BMY $CELG  https://t.co/twaHHRgwDe",en,[],['https://endpts.com/playing-hardball-bristol-myers-bought-out-a-battered-celgene-with-last-minute-terms-sweetened-in-its-favor/'],[],1,1,6,[],"['bmy', 'celg']",https://twitter.com/JohnCendpts/status/1091343432377880576,False,,0,,,,,,,,[],,,,
1091318669320339461,1091318669320339461,2019-02-01 18:23:41 IST,2019-02-01,18:23:41,+0530,873399943,jacobplieth,Jacob Plieth,,Perhaps his biggest mistake was not to have leaked it $CELG $BMY,en,[],[],[],2,0,19,[],"['celg', 'bmy']",https://twitter.com/JacobPlieth/status/1091318669320339461,False,https://twitter.com/AndyBiotech/status/1091317458026328066,0,,,,,,,,[],,,,
1090218961353039872,1090218961353039872,2019-01-29 17:33:50 IST,2019-01-29,17:33:50,+0530,102754598,johncendpts,John Carroll,,Celgene rolls along with another epigenetic preclinical deal featuring a Canadian biotech $CELG  https://t.co/4GTneS4nQ6,en,[],['https://endpts.com/celgene-rolls-along-with-another-epigenetic-preclinical-deal-featuring-a-canadian-biotech/'],[],1,9,16,[],['celg'],https://twitter.com/JohnCendpts/status/1090218961353039872,False,,0,,,,,,,,[],,,,
1089615526828027905,1089615526828027905,2019-01-28 01:36:00 IST,2019-01-28,01:36:00,+0530,274233761,bradloncar,Brad Loncar,,"Celgene also has a call listed on its website for Thursday at 9:00AM ET, although they haven't officially announced that in a press release. $CELG",en,[],[],[],2,1,11,[],['celg'],https://twitter.com/bradloncar/status/1089615526828027905,False,,0,,,,,,,,[],,,,
1088466754647412746,1088466754647412746,2019-01-24 21:31:11 IST,2019-01-24,21:31:11,+0530,368158573,rebeccadrobbins,Rebecca Robbins,,Just finished recording the latest episode of our biotech podcast. @matthewherper joins us to talk about the future of CRISPR company $EDIT and the legacy of $CELG. And then we talk about dogs. Listen when the ep drops this afternoon üëá  https://t.co/0syC9RYORM,en,"[{'screen_name': 'matthewherper', 'name': 'matthew herper', 'id': '44438256'}]",['https://www.statnews.com/category/readout-loud/'],[],0,0,10,[],"['edit', 'celg']",https://twitter.com/RebeccaDRobbins/status/1088466754647412746,False,,0,,,,,,,,[],,,,
1088437415751110656,1088437415751110656,2019-01-24 19:34:36 IST,2019-01-24,19:34:36,+0530,873399943,jacobplieth,Jacob Plieth,,Kudos to Tim Anderson for asking $BMY whether $CELG was a poison pill. Totally non-committal reply,en,[],[],[],7,7,31,[],"['bmy', 'celg']",https://twitter.com/JacobPlieth/status/1088437415751110656,False,,0,,,,,,,,[],,,,
1087706079172141056,1087706079172141056,2019-01-22 19:08:32 IST,2019-01-22,19:08:32,+0530,47678782,megtirrell,Meg Tirrell,,Have to love Geoff Porges‚Äô fearlessness to provide a real opinion. And great ‚Å¶@matthewherper‚Å© tale as always. $CELG  https://t.co/fHlzyPT1Fr  https://t.co/SCEfawQDwA,en,"[{'screen_name': 'matthewherper', 'name': 'matthew herper', 'id': '44438256'}]",['https://www.statnews.com/2019/01/22/celgene-legacy-chutzpah-science-drug-pricing'],['https://pbs.twimg.com/media/DxhO6acWsAMWdVd.jpg'],1,8,41,[],['celg'],https://twitter.com/megtirrell/status/1087706079172141056,False,,1,https://pbs.twimg.com/media/DxhO6acWsAMWdVd.jpg,,,,,,,[],,,,
1087703478598811648,1087703478598811648,2019-01-22 18:58:12 IST,2019-01-22,18:58:12,+0530,44438256,matthewherper,Matthew Herper,,"OK. I have my second cup of tea and I am ready to start social media-ing for real. For all the people who were asking me if I was going to be doing long narratives at @statnews, there are 2,000 words on $CELG up for you.  https://t.co/JxsOqBDVq7  More in a few.",en,"[{'screen_name': 'statnews', 'name': 'stat', 'id': '3290364847'}]",['https://www.statnews.com/2019/01/22/celgene-legacy-chutzpah-science-drug-pricing/'],[],7,13,48,[],['celg'],https://twitter.com/matthewherper/status/1087703478598811648,False,,0,,,,,,,,[],,,,
1087692571143475201,1087692571143475201,2019-01-22 18:14:51 IST,2019-01-22,18:14:51,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$CELG, sold for $74 billion, leaves a legacy of chutzpah in science and drug pricing  https://t.co/n0sCNLmuPg @matthewherper pens the definitive Celgene obit. This is a compelling read, starting with a cabbie's stock tip.",en,"[{'screen_name': 'matthewherper', 'name': 'matthew herper', 'id': '44438256'}]",['https://www.statnews.com/2019/01/22/celgene-legacy-chutzpah-science-drug-pricing/'],[],2,11,31,[],['celg'],https://twitter.com/adamfeuerstein/status/1087692571143475201,False,,0,,,,,,,,[],,,,
1087423414145560576,1087423414145560576,2019-01-22 00:25:19 IST,2019-01-22,00:25:19,+0530,14886375,stocktwits,Stocktwits,,Earnings this week:  Tue - $IBM $JNJ $HAL $AMTD Wed - $F $PG $DBX $ABT Thu - $INTC $SBUX $CELG Fri - $ABBV $CL   https://t.co/wiZyO71Kyg,en,[],['https://www.stocktwits.com/discover/earnings-calendar'],[],7,24,33,[],"['ibm', 'jnj', 'hal', 'amtd', 'f', 'pg', 'dbx', 'abt', 'intc', 'sbux', 'celg', 'abbv', 'cl']",https://twitter.com/Stocktwits/status/1087423414145560576,False,,0,,,,,,,,[],,,,
1086004017078173701,1086004017078173701,2019-01-18 02:25:09 IST,2019-01-18,02:25:09,+0530,102754598,johncendpts,John Carroll,,Celgene related?  Scoop: Forma axes discovery biology team as part of a broader reorganization $CELG  https://t.co/Gn7hJCNWBt,en,[],['https://endpts.com/scoop-forma-axes-discovery-biology-team-as-part-of-a-broader-reorganization/'],[],1,6,7,[],['celg'],https://twitter.com/JohnCendpts/status/1086004017078173701,False,,0,,,,,,,,[],,,,
1085556062860820485,1085556062860820485,2019-01-16 20:45:08 IST,2019-01-16,20:45:08,+0530,475309726,tradestation,TradeStation,,"#Biotech stocks are off to a healthy start in 2019, thanks to some big-name #takeovers involving #Celgene $CELG and #BristolMyersSquibb $BMY, as well as #LoxoOncology $LOXO and #EliLilly $LLY. Check out the other names rising to the top.  https://t.co/7XLSKNK0Mw  https://t.co/biWmOkxREW",en,[],['https://bit.ly/2HdY71q'],['https://pbs.twimg.com/media/DxCrfEgWkAA6iwU.jpg'],0,6,29,"['biotech', 'takeovers', 'celgene', 'bristolmyerssquibb', 'loxooncology', 'elililly']","['celg', 'bmy', 'loxo', 'lly']",https://twitter.com/TradeStation/status/1085556062860820485,False,,1,https://pbs.twimg.com/media/DxCrfEgWkAA6iwU.jpg,,,,,,,[],,,,
1085209090966605825,1085209090966605825,2019-01-15 21:46:24 IST,2019-01-15,21:46:24,+0530,873399943,jacobplieth,Jacob Plieth,,"What does $PFE do after losing $BMY? My take on the knock-on effect of $CELG (oh, and $GSK &amp; $AZN need to merge)  https://t.co/rzAkwixzyJ",en,[],['http://bit.ly/2Cm3s1i'],[],5,18,32,[],"['pfe', 'bmy', 'celg', 'gsk', 'azn']",https://twitter.com/JacobPlieth/status/1085209090966605825,False,,0,,,,,,,,[],,,,
1084879260651843586,1084860377828126720,2019-01-14 23:55:46 IST,2019-01-14,23:55:46,+0530,42782695,berkeleyjr,Berkeley Lovelace,,The 12 companies that the panel requested information from:  AbbVie $ABBV Amgen $AMGN AstraZeneca $AZN Celgene $CELG Eli Lilly $LLY Johnson &amp; Johnson $JNJ Mallinckrodt $MNK Novartis $NVS Novo Nordisk $NVO Pfizer $PFE Sanofi $SNY Teva Pharmaceuticals $TEVA,en,[],[],[],1,3,6,[],"['abbv', 'amgn', 'azn', 'celg', 'lly', 'jnj', 'mnk', 'nvs', 'nvo', 'pfe', 'sny', 'teva']",https://twitter.com/BerkeleyJr/status/1084879260651843586,False,,0,,,,,,,,[],,,,
1084851393058480128,1084851393058480128,2019-01-14 22:05:02 IST,2019-01-14,22:05:02,+0530,42703163,sarahkarlin,Sarah Karlin-Smith,,"all the big guys are on the list: $PFE, $JNJ, $LLY, $SNY, $NVO, $ABBV, $AMGN, $AZN, $TEVA, $MNK, $CELG, $NVS   a good reminder that the drug pricing practices lawmakers are concerned about are not limited to Martin Shkreli-types.",en,[],[],[],2,28,38,[],"['pfe', 'jnj', 'lly', 'sny', 'nvo', 'abbv', 'amgn', 'azn', 'teva', 'mnk', 'celg', 'nvs']",https://twitter.com/SarahKarlin/status/1084851393058480128,False,https://twitter.com/abettel/status/1084850631616196609,0,,,,,,,,[],,,,
1082664978732191744,1082664978732191744,2019-01-08 21:17:00 IST,2019-01-08,21:17:00,+0530,873399943,jacobplieth,Jacob Plieth,,"This BCMA antibody-drug conjugate could be on the market in 2020, $GSK says #JPM19 $CELG $BLUE $BMY $GILD",en,[],[],[],0,8,9,['jpm19'],"['gsk', 'celg', 'blue', 'bmy', 'gild']",https://twitter.com/JacobPlieth/status/1082664978732191744,False,https://twitter.com/ByMadeleineA/status/1082664294683107328,0,,,,,,,,[],,,,
1082625458422788096,1082625458422788096,2019-01-08 18:39:58 IST,2019-01-08,18:39:58,+0530,102754598,johncendpts,John Carroll,,Lots of buzz at #JPM19 about Celgene of course. Consensus opinion I'm hearing: Alles and his crew caved rather than fight it out. The CVR is weak. The company changed from a winner to a loser in 18 months. It's all a damn shame. $CELG $BMY,en,[],[],[],8,9,59,['jpm19'],"['celg', 'bmy']",https://twitter.com/JohnCendpts/status/1082625458422788096,False,,0,,,,,,,,[],,,,
1082327302539747328,1082327302539747328,2019-01-07 22:55:12 IST,2019-01-07,22:55:12,+0530,873399943,jacobplieth,Jacob Plieth,,If $BMY repeats it often enough perhaps someone will believe that the $CELG acquisition isn't a defensive move #JPM19,en,[],[],[],0,1,8,['jpm19'],"['bmy', 'celg']",https://twitter.com/JacobPlieth/status/1082327302539747328,False,https://twitter.com/ByMadeleineA/status/1082302591449456641,0,,,,,,,,[],,,,
1082282412502016002,1082282412502016002,2019-01-07 19:56:49 IST,2019-01-07,19:56:49,+0530,295746612,faycortez,Michelle Fay Cortez,,"Amid all the excitement of M&amp;A ($LOXO $LLY $CELG $BMY) and positive phase 3 results ($SAGE) at #JPM19, don't overlook the risks (released late Friday; funny how that works):  https://t.co/b8Xk0ofvwi",en,[],[],['https://pbs.twimg.com/media/DwUKDabVsAEFpv4.jpg'],0,1,4,['jpm19'],"['lly', 'celg', 'bmy']",https://twitter.com/FayCortez/status/1082282412502016002,False,,1,https://pbs.twimg.com/media/DwUKDabVsAEFpv4.jpg,,,,,,,[],,,,
1082279637214883840,1082279637214883840,2019-01-07 19:45:47 IST,2019-01-07,19:45:47,+0530,3043828834,cgrantwsj,Charley Grant,,Second deal premium in a week that essentially ignores recent biopharma selloff. That‚Äôs bullish. $XBI $LOXO $CELG,en,[],[],[],4,6,35,[],"['xbi', 'loxo', 'celg']",https://twitter.com/CGrantWSJ/status/1082279637214883840,False,https://twitter.com/adamfeuerstein/status/1082238616519139330,0,,,,,,,,[],,,,
1082268886907662336,1082268886907662336,2019-01-07 19:03:04 IST,2019-01-07,19:03:04,+0530,370238655,jodigralnick,jodi gralnick,,"ONE HOUR AWAY: CEOs of $BMY &amp; $CELG join @jimcramer on @CNBC @SquawkStreet to talk about the big merger, approx. 930amET/630amPT - LIVE and EXCLUSIVE at #JPM19! @bmsnews‚Å© ‚Å¶@Celgene‚Å©",en,"[{'screen_name': 'jimcramer', 'name': 'jim cramer', 'id': '14216123'}, {'screen_name': 'cnbc', 'name': 'cnbc', 'id': '20402945'}, {'screen_name': 'squawkstreet', 'name': 'squawk on the street', 'id': '106498703'}, {'screen_name': 'bmsnews', 'name': 'bristol myers squibb', 'id': '34010976'}, {'screen_name': 'celgene', 'name': 'jin', 'id': '1350978062125588490'}]",[],[],2,2,10,['jpm19'],"['bmy', 'celg']",https://twitter.com/jodigralnick/status/1082268886907662336,False,,0,,,,,,,,[],,,,
1082268118393802753,1082268118393802753,2019-01-07 19:00:01 IST,2019-01-07,19:00:01,+0530,34010976,bmsnews,Bristol Myers Squibb,,"Watch our Chairman and CEO Giovanni Caforio this morning on CNBC w/ @jimcramer &amp; @Celgene Chairman and CEO Mark Alles, discussing last week‚Äôs Celgene announcement and more, ~9:30 a.m. ET/6:30 a.m. PT from #JPM19 $BMY $CELG  https://t.co/5szWvORREt",en,"[{'screen_name': 'jimcramer', 'name': 'jim cramer', 'id': '14216123'}, {'screen_name': 'celgene', 'name': 'jin', 'id': '1350978062125588490'}]",[],['https://pbs.twimg.com/media/DwT9HkMWoAAo_RZ.jpg'],0,4,21,['jpm19'],"['bmy', 'celg']",https://twitter.com/bmsnews/status/1082268118393802753,False,,1,https://pbs.twimg.com/media/DwT9HkMWoAAo_RZ.jpg,,,,,,,[],,,,
1082095433785245696,1082095433785245696,2019-01-07 07:33:50 IST,2019-01-07,07:33:50,+0530,34010976,bmsnews,Bristol Myers Squibb,,"Watch our Chairman and CEO Giovanni Caforio tomorrow morning on CNBC w/ @jimcramer &amp; @Celgene Chairman and CEO Mark Alles, discussing last week‚Äôs Celgene announcement and more, ~9:30 a.m. ET/6:30 a.m. PT from #JPM19 $BMY $CELG  https://t.co/A3cdhNznUz",en,"[{'screen_name': 'jimcramer', 'name': 'jim cramer', 'id': '14216123'}, {'screen_name': 'celgene', 'name': 'jin', 'id': '1350978062125588490'}]",[],['https://pbs.twimg.com/media/DwRfzpUWkAAL-jT.jpg'],0,10,17,['jpm19'],"['bmy', 'celg']",https://twitter.com/bmsnews/status/1082095433785245696,False,,1,https://pbs.twimg.com/media/DwRfzpUWkAAL-jT.jpg,,,,,,,[],,,,
1081999324060545029,1081999324060545029,2019-01-07 01:11:56 IST,2019-01-07,01:11:56,+0530,370238655,jodigralnick,jodi gralnick,,"REMINDER: @CNBC #JPM19 coverage kicks off tomorrow: CEOs of $BMY &amp; $CELG join @jimcramer on @SquawkStreet to talk about the big merger, approx. 930amET/630amPT - LIVE and EXCLUSIVE! (then stick around for $LLY and $GSK CEOs, all before noon ET) ‚Å¶@bmsnews‚Å© ‚Å¶@Celgene‚Å©  https://t.co/ydkDQwrnCF",en,"[{'screen_name': 'cnbc', 'name': 'cnbc', 'id': '20402945'}, {'screen_name': 'jimcramer', 'name': 'jim cramer', 'id': '14216123'}, {'screen_name': 'squawkstreet', 'name': 'squawk on the street', 'id': '106498703'}, {'screen_name': 'bmsnews', 'name': 'bristol myers squibb', 'id': '34010976'}, {'screen_name': 'celgene', 'name': 'jin', 'id': '1350978062125588490'}]",[],['https://pbs.twimg.com/media/DwQIo5kXgAADrFY.jpg'],3,6,15,['jpm19'],"['bmy', 'celg', 'lly', 'gsk']",https://twitter.com/jodigralnick/status/1081999324060545029,False,,1,https://pbs.twimg.com/media/DwQIo5kXgAADrFY.jpg,,,,,,,[],,,,
1081896690922242049,1081896690922242049,2019-01-06 18:24:06 IST,2019-01-06,18:24:06,+0530,370238655,jodigralnick,jodi gralnick,,"Here we go... off to the airport for my flight to #JPM19. Tune in to @CNBC all day tomorrow and Tuesday for @jimcramer coverage, and interviews w/ CEOs of $BMY, $CELG, $LLY, $GSK, $ALLO, $MRNA, $MDT, $CI, $EDIT, more. Starting on @SquawkStreet tomorrow.",en,"[{'screen_name': 'cnbc', 'name': 'cnbc', 'id': '20402945'}, {'screen_name': 'jimcramer', 'name': 'jim cramer', 'id': '14216123'}, {'screen_name': 'squawkstreet', 'name': 'squawk on the street', 'id': '106498703'}]",[],[],4,7,25,['jpm19'],"['bmy', 'celg', 'lly', 'gsk', 'allo', 'mrna', 'mdt', 'ci', 'edit']",https://twitter.com/jodigralnick/status/1081896690922242049,False,,0,,,,,,,,[],,,,
1081320680141058050,1081320680141058050,2019-01-05 04:15:14 IST,2019-01-05,04:15:14,+0530,370238655,jodigralnick,jodi gralnick,,"SET YOUR ALARM: @CNBC coverage of #JPM19 kicks off in a big way: CEOs of $BMY &amp; $CELG join ‚Å¶@jimcramer‚Å© on ‚Å¶@SquawkStreet‚Å© to talk about the big merger, approx. 930amET/630amPT Monday - LIVE and EXCLUSIVE! (then stick around for $LLY and $GSK CEOs, all before noon ET)  https://t.co/pfUYviRSOu",en,"[{'screen_name': 'cnbc', 'name': 'cnbc', 'id': '20402945'}, {'screen_name': 'jimcramer', 'name': 'jim cramer', 'id': '14216123'}, {'screen_name': 'squawkstreet', 'name': 'squawk on the street', 'id': '106498703'}]",[],['https://pbs.twimg.com/media/DwGfbGsUYAAz3bv.jpg'],1,12,13,['jpm19'],"['bmy', 'celg', 'lly', 'gsk']",https://twitter.com/jodigralnick/status/1081320680141058050,False,,1,https://pbs.twimg.com/media/DwGfbGsUYAAz3bv.jpg,,,,,,,[],,,,
1081258357170819072,1081258357170819072,2019-01-05 00:07:35 IST,2019-01-05,00:07:35,+0530,295746612,faycortez,Michelle Fay Cortez,,Bristol's code name for $CELG? Champagne. Word association: bubbles. Hm. Working through the holidays helped Bristol-Myers seal the biggest-ever pharma deal by the third day of the new year  https://t.co/FnQCa0lK2P via @business,en,"[{'screen_name': 'business', 'name': 'bloomberg', 'id': '34713362'}]",['https://www.bloomberg.com/news/articles/2019-01-04/holiday-sacrifice-brings-new-year-s-champagne-for-bristol-myers'],[],0,2,5,[],['celg'],https://twitter.com/FayCortez/status/1081258357170819072,False,,0,,,,,,,,[],,,,
1080981205795856386,1080981205795856386,2019-01-04 05:46:17 IST,2019-01-04,05:46:17,+0530,33669217,kerrydolan,Kerry Dolan,,Bristol-Myers Squibb $BMY And Celgene's $CELG Big Winner? Los Angeles #Billionaire Patrick Soon-Shiong via @forbes  https://t.co/zqhm1pfJg7,en,"[{'screen_name': 'forbes', 'name': 'forbes', 'id': '91478624'}]",['https://www.forbes.com/sites/michelatindera/2019/01/03/bristol-myers-squibb-and-celgenes-big-winner-los-angeles-billionaire-patrick-soon-shiong/#1be63046423c'],[],0,4,12,['billionaire'],"['bmy', 'celg']",https://twitter.com/KerryDolan/status/1080981205795856386,False,,0,,,,,,,,[],,,,
1080968811468140546,1080968811468140546,2019-01-04 04:57:02 IST,2019-01-04,04:57:02,+0530,368158573,rebeccadrobbins,Rebecca Robbins,,"The latest ep of our biotech podcast is out! Tune in for: üîπa breakdown of $BMY $CELG palooza, ft. @matthewherper  üîπa preview of #jpm19 üîπa Letterman-style top 10 list of what not to say on the #jpm19 stage, ft. @MikeHuckman   https://t.co/Y3zBfOx23t",en,"[{'screen_name': 'matthewherper', 'name': 'matthew herper', 'id': '44438256'}, {'screen_name': 'mikehuckman', 'name': 'mike huckman', 'id': '24196664'}]",['https://www.statnews.com/2019/01/03/podcast-bristol-myers-celgene-jpm-preview/'],[],0,1,8,"['jpm19', 'jpm19']","['bmy', 'celg']",https://twitter.com/RebeccaDRobbins/status/1080968811468140546,False,,0,,,,,,,,[],,,,
1080932184414961664,1080932184414961664,2019-01-04 02:31:30 IST,2019-01-04,02:31:30,+0530,102094857,adamfeuerstein,Adam Feuerstein,,9 big takeaways from the $74 billion Bristol-Celgene deal  https://t.co/nsDmwtPuoW The gif illustration created by our @hoganalex is üëç $CELG $BMY,en,"[{'screen_name': 'hoganalex', 'name': 'alex hogan', 'id': '296572811'}]",['https://www.statnews.com/2019/01/03/9-big-takeaways-from-the-74-billion-bristol-celgene-deal/'],[],0,8,9,[],"['celg', 'bmy']",https://twitter.com/adamfeuerstein/status/1080932184414961664,False,,0,,,,,,,,[],,,,
1080930948408053762,1080930948408053762,2019-01-04 02:26:35 IST,2019-01-04,02:26:35,+0530,15971805,investorslive,Nathan Michaud,,$CELG nice finish - done for today.  https://t.co/1TgMLcyeoT,en,[],[],['https://pbs.twimg.com/media/DwA87B8WkAAGCs5.jpg'],1,1,20,[],['celg'],https://twitter.com/InvestorsLive/status/1080930948408053762,False,,1,https://pbs.twimg.com/media/DwA87B8WkAAGCs5.jpg,,,,,,,[],,,,
1080895873616367616,1080895873616367616,2019-01-04 00:07:13 IST,2019-01-04,00:07:13,+0530,102754598,johncendpts,John Carroll,,"I'm wondering what Bob Hugin thinks about this $CELG buyout. Would he have taken $74B, or believed enough in the pipeline to wait for a couple of solid hits? I can guess.",en,[],[],[],2,0,6,[],['celg'],https://twitter.com/JohnCendpts/status/1080895873616367616,False,,0,,,,,,,,[],,,,
1080892692450680832,1080892692450680832,2019-01-03 23:54:34 IST,2019-01-03,23:54:34,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Why Bristol-Myers Squibb‚Äôs Giovanni Caforio is buying Celgene, in his own words  https://t.co/SvQsJt7Gfo @matthewherper spoke with Caforio and $CELG CEO Mark Alles $BMY",en,"[{'screen_name': 'matthewherper', 'name': 'matthew herper', 'id': '44438256'}]",['https://www.statnews.com/2019/01/03/why-bristol-myers-squibbs-giovanni-caforio-is-buying-celgene-in-his-own-words/'],[],1,3,11,[],"['celg', 'bmy']",https://twitter.com/adamfeuerstein/status/1080892692450680832,False,,0,,,,,,,,[],,,,
1080886510830997506,1080886081917280258,2019-01-03 23:30:00 IST,2019-01-03,23:30:00,+0530,873399943,jacobplieth,Jacob Plieth,,"@CGrantWSJ I was just wondering whether $BMY bought $CELG partly as a poison pill to avoid getting bought itself by, say, $PFE",en,[],[],[],2,1,15,[],"['bmy', 'celg', 'pfe']",https://twitter.com/JacobPlieth/status/1080886510830997506,False,,0,,,,,,,,"[{'screen_name': 'CGrantWSJ', 'name': 'Charley Grant', 'id': '3043828834'}]",,,,
1080886081917280258,1080886081917280258,2019-01-03 23:28:18 IST,2019-01-03,23:28:18,+0530,3043828834,cgrantwsj,Charley Grant,,"Bristol-Myers stock is getting hammered, but are things really that bad? $BMY $CELG   https://t.co/JPMVSgQxfq",en,[],['https://www.wsj.com/articles/bristol-myers-and-celgene-side-effects-will-be-temporary-11546526507'],[],4,5,11,[],"['bmy', 'celg']",https://twitter.com/CGrantWSJ/status/1080886081917280258,False,,0,,,,,,,,[],,,,
1080863939053813760,1080863939053813760,2019-01-03 22:00:19 IST,2019-01-03,22:00:19,+0530,368158573,rebeccadrobbins,Rebecca Robbins,,We just finished recording the latest ep of our biotech podcast. Our guests: üîπ @matthewherper helps us break down the $BMY $CELG deal üîπ @MikeHuckman shares his Top 10 list of what not to say on the #JPM19 stage  Find the show later this afternoon üëá  https://t.co/0syC9RYORM,en,"[{'screen_name': 'matthewherper', 'name': 'matthew herper', 'id': '44438256'}, {'screen_name': 'mikehuckman', 'name': 'mike huckman', 'id': '24196664'}]",['https://www.statnews.com/category/readout-loud/'],[],0,6,26,['jpm19'],"['bmy', 'celg']",https://twitter.com/RebeccaDRobbins/status/1080863939053813760,False,,0,,,,,,,,[],,,,
1080854445485899776,1080854445485899776,2019-01-03 21:22:35 IST,2019-01-03,21:22:35,+0530,25065878,becker_michaeld,Michael D. Becker,,"Successful M&amp;A is sometimes described by the expression 1 + 1 = 3, reflecting the fact that the resulting company may have increased market share/power, cost synergies, and may gain access to new technologies. So, does $BMY plus $CELG equal three, two, or less?",en,[],[],[],0,0,5,[],"['bmy', 'celg']",https://twitter.com/Becker_MichaelD/status/1080854445485899776,False,,0,,,,,,,,[],,,,
1080850127487713280,1080850127487713280,2019-01-03 21:05:26 IST,2019-01-03,21:05:26,+0530,873399943,jacobplieth,Jacob Plieth,,$BMY &amp; $CELG set the bar for #JPM18. Via @Vantageanalysis  https://t.co/pglHQGoYqA,en,"[{'screen_name': 'vantageanalysis', 'name': 'evaluate vantage', 'id': '3033767986'}]",['http://bit.ly/2R3b3Ml'],[],1,5,7,['jpm18'],"['bmy', 'celg']",https://twitter.com/JacobPlieth/status/1080850127487713280,False,,0,,,,,,,,[],,,,
1080839591387631617,1080839591387631617,2019-01-03 20:23:34 IST,2019-01-03,20:23:34,+0530,295746612,faycortez,Michelle Fay Cortez,,The real shocker with the $BMY $CELG deal: it was pure breaking news. It wasn't forecast (though many speculated). It wasn't leaked by bankers. I can't think of another major M&amp;A deal in biopharma that broke with a press release. Impressive.,en,[],[],[],4,27,113,[],"['bmy', 'celg']",https://twitter.com/FayCortez/status/1080839591387631617,False,,0,,,,,,,,[],,,,
1080835233061224449,1080835233061224449,2019-01-03 20:06:15 IST,2019-01-03,20:06:15,+0530,15563814,loftus,Peter Loftus,,"Celgene shares jump 28%, Bristol-Myers drops 12% after news of Bristol's $74B acquisition of Celgene $CELG $BMY",en,[],[],[],1,5,7,[],"['celg', 'bmy']",https://twitter.com/Loftus/status/1080835233061224449,False,,0,,,,,,,,[],,,,
1080832740319211520,1080832740319211520,2019-01-03 19:56:20 IST,2019-01-03,19:56:20,+0530,1278852289,tradingnation,Trading Nation,,Shares of Celgene soaring in the premarket after Bristol-Myers agreed to buy the biotech company for $74 billion $CELG $BMY  https://t.co/TbHzqTNEm4,en,[],[],['https://pbs.twimg.com/media/Dv_jn0iX4AAQ9jm.png'],2,7,14,[],"['celg', 'bmy']",https://twitter.com/TradingNation/status/1080832740319211520,False,,1,https://pbs.twimg.com/media/Dv_jn0iX4AAQ9jm.png,,,,,,,[],,,,
1080832196678742017,1080832196678742017,2019-01-03 19:54:11 IST,2019-01-03,19:54:11,+0530,16838276,philstockworld,Phil Davis,,Thursday Freak Out - #Apple Profit Warning Wrecks The Recovery $AAPL Also $BMY $CELG $NDX  https://t.co/6LhiZkTd62,en,[],['https://goo.gl/msREs1'],[],0,0,3,['apple'],"['aapl', 'bmy', 'celg', 'ndx']",https://twitter.com/philstockworld/status/1080832196678742017,False,,0,,,,,,,,[],,,,
1080827571024158722,1080827571024158722,2019-01-03 19:35:48 IST,2019-01-03,19:35:48,+0530,102754598,johncendpts,John Carroll,,"I'm sorry to see $CELG go. They've been a huge source of news over the years. Recently it's soured, but they were on to big things. Great partners, too. But this current team....",en,[],[],[],2,2,30,[],['celg'],https://twitter.com/JohnCendpts/status/1080827571024158722,False,,0,,,,,,,,[],,,,
1080818663316484097,1080818663316484097,2019-01-03 19:00:24 IST,2019-01-03,19:00:24,+0530,102754598,johncendpts,John Carroll,,"UPDATED: Bristol-Myers inks a $74B deal to buy out Celgene, expects $15B a year from late-stage pipeline $BMY $CELG  https://t.co/glLgaax4WU",en,[],['https://endpts.com/bristol-myers-inks-a-74b-deal-to-buy-out-celgene-expects-15b-a-year-from-late-stage-pipeline/'],[],0,8,17,[],"['bmy', 'celg']",https://twitter.com/JohnCendpts/status/1080818663316484097,False,,0,,,,,,,,[],,,,
1080818293211049991,1080818293211049991,2019-01-03 18:58:56 IST,2019-01-03,18:58:56,+0530,47678782,megtirrell,Meg Tirrell,,Keeping with tradition ‚Äî of course this happens while I‚Äôm on maternity leave! $BMY $CELG,en,[],[],[],23,5,179,[],"['bmy', 'celg']",https://twitter.com/megtirrell/status/1080818293211049991,False,https://twitter.com/adamfeuerstein/status/1080811702160101382,0,,,,,,,,[],,,,
1080816542873518080,1080816542873518080,2019-01-03 18:51:59 IST,2019-01-03,18:51:59,+0530,153495347,sherman4949,Alex Sherman,,Note: BofA was not a bank on the $BMY $CELG deal.,en,[],[],[],0,1,7,[],"['bmy', 'celg']",https://twitter.com/sherman4949/status/1080816542873518080,False,https://twitter.com/DavidSchawel/status/1080815609619849216,0,,,,,,,,[],,,,
1080814357360070657,1080814357360070657,2019-01-03 18:43:18 IST,2019-01-03,18:43:18,+0530,16732770,cnbcfastmoney,CNBC's Fast Money,,Celgene up 33% pre-market after Bristol-Myers said it would acquire the company for $74B. Check out @petenajarian's pitch for $CELG back in October,en,"[{'screen_name': 'petenajarian', 'name': 'pete najarian', 'id': '14292717'}]",[],[],7,16,65,[],['celg'],https://twitter.com/CNBCFastMoney/status/1080814357360070657,False,https://twitter.com/CNBCFastMoney/status/1057752108475314176,0,,,,,,,,[],,,,
1080809075791802368,1080809075791802368,2019-01-03 18:22:18 IST,2019-01-03,18:22:18,+0530,104952689,lamonicabuzz,Paul R. La Monica,,The huge drug merger won't be enough to offset Apple/tech/China fears today. $CELG may be surging after $BMY bought it but market futures are still down sharply on $AAPL sales warning.,en,[],[],[],0,1,5,[],"['celg', 'bmy', 'aapl']",https://twitter.com/LaMonicaBuzz/status/1080809075791802368,False,,0,,,,,,,,[],,,,
1080809070091739136,1080809070091739136,2019-01-03 18:22:17 IST,2019-01-03,18:22:17,+0530,15563814,loftus,Peter Loftus,,"Bristol-Myers is buying Celgene, maker of blockbuster cancer drugs, for $74 billion $BMY $CELG  https://t.co/0qNfwNeU3d via @WSJ",en,"[{'screen_name': 'wsj', 'name': 'the wall street journal', 'id': '3108351'}]",['https://www.wsj.com/articles/bristol-myers-squibb-to-acquire-celgene-11546517754'],[],1,6,15,[],"['bmy', 'celg']",https://twitter.com/Loftus/status/1080809070091739136,False,,0,,,,,,,,[],,,,
1080807775364616193,1080807775364616193,2019-01-03 18:17:08 IST,2019-01-03,18:17:08,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Amazing to think that $CELG is going away with the $BMY buy.,en,[],[],[],3,6,47,[],"['celg', 'bmy']",https://twitter.com/adamfeuerstein/status/1080807775364616193,False,,0,,,,,,,,[],,,,
1080805442371158016,1080796907352539137,2019-01-03 18:07:52 IST,2019-01-03,18:07:52,+0530,873399943,jacobplieth,Jacob Plieth,,$74bn makes $BMY $CELG the fourth-biggest pharma megamerger. Via @EdwinElmhirst  https://t.co/UQWAscAwqA,en,"[{'screen_name': 'edwinelmhirst', 'name': 'edwin elmhirst', 'id': '697732860741029888'}]",[],['https://pbs.twimg.com/media/Dv_KzQLXQAAh0HP.jpg'],1,24,25,[],"['bmy', 'celg']",https://twitter.com/JacobPlieth/status/1080805442371158016,False,,1,https://pbs.twimg.com/media/Dv_KzQLXQAAh0HP.jpg,,,,,,,[],,,,
1080803271613255680,1080803271613255680,2019-01-03 17:59:14 IST,2019-01-03,17:59:14,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Bristol-Myers Squibb will acquire Celgene in blockbuster $74B deal  https://t.co/T4ILLgj5Xh $BMY $CELG and first co-byline from Matt and me.,en,[],['https://www.statnews.com/2019/01/03/bristol-myers-to-acquire-celgene/'],[],1,51,86,[],"['bmy', 'celg']",https://twitter.com/adamfeuerstein/status/1080803271613255680,False,,0,,,,,,,,[],,,,
1080800892809555968,1080800892809555968,2019-01-03 17:49:47 IST,2019-01-03,17:49:47,+0530,102754598,johncendpts,John Carroll,,"Bristol-Myers inks a $74B deal to buy out Celgene, expects $15B a year from late-stage pipeline $BMY $CELG  https://t.co/glLgaax4WU",en,[],['https://endpts.com/bristol-myers-inks-a-74b-deal-to-buy-out-celgene-expects-15b-a-year-from-late-stage-pipeline/'],[],0,36,28,[],"['bmy', 'celg']",https://twitter.com/JohnCendpts/status/1080800892809555968,False,,0,,,,,,,,[],,,,
1080797839624757248,1080797839624757248,2019-01-03 17:37:39 IST,2019-01-03,17:37:39,+0530,3043828834,cgrantwsj,Charley Grant,,"Heard on the Street flagged $CELG as particularly cheap last week. Today, $BMY announces an acquisition.  https://t.co/TqaBluSyeG",en,[],['https://www.wsj.com/articles/what-to-buy-after-the-stock-market-selloff-11545994800'],[],2,7,23,[],"['celg', 'bmy']",https://twitter.com/CGrantWSJ/status/1080797839624757248,False,,0,,,,,,,,[],,,,
1080797097891450881,1080797097891450881,2019-01-03 17:34:43 IST,2019-01-03,17:34:43,+0530,15281391,thestreet,TheStreet,,Breaking -- Bristol-Myers $BMY to Buy Celgene $CELG in Deal Valued at $74 Billion. More to follow on  https://t.co/o6IinmgxZm,en,[],['http://TheStreet.com'],[],2,11,18,[],"['bmy', 'celg']",https://twitter.com/TheStreet/status/1080797097891450881,False,,0,,,,,,,,[],,,,
1080796907352539137,1080796907352539137,2019-01-03 17:33:57 IST,2019-01-03,17:33:57,+0530,873399943,jacobplieth,Jacob Plieth,,"2018 stock performances: $BMY -15%. $CELG -39%. Sure, why not?",en,[],[],[],1,2,5,[],"['bmy', 'celg']",https://twitter.com/JacobPlieth/status/1080796907352539137,False,https://twitter.com/odibro/status/1080796320825294848,0,,,,,,,,[],,,,
1080795795924881408,1080795795924881408,2019-01-03 17:29:32 IST,2019-01-03,17:29:32,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$BMY buying $CELG ‚Äî WOWZA!!!,en,[],[],[],16,53,195,[],"['bmy', 'celg']",https://twitter.com/adamfeuerstein/status/1080795795924881408,False,,0,,,,,,,,[],,,,
1080181201829314560,1080181201829314560,2019-01-02 00:47:21 IST,2019-01-02,00:47:21,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"No Jan. 1 price increases for $CELG $AMGN $GILD. $BIIB raised Tecfidera 6%, per ISI‚Äôs Umer Raffat.",et,[],[],[],3,3,13,[],"['celg', 'amgn', 'gild', 'biib']",https://twitter.com/adamfeuerstein/status/1080181201829314560,False,,0,,,,,,,,[],,,,
1076200916452290560,1076200916452290560,2018-12-22 01:11:07 IST,2018-12-22,01:11:07,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Seemed fitting to look at #JPM16 tweets. Found this one‚Ä¶. $CELG,en,[],[],[],1,0,10,['jpm16'],['celg'],https://twitter.com/adamfeuerstein/status/1076200916452290560,False,https://twitter.com/adamfeuerstein/status/686684310477221889,0,,,,,,,,[],,,,
1075806616241483777,1075806616241483777,2018-12-20 23:04:19 IST,2018-12-20,23:04:19,+0530,44438256,matthewherper,Matthew Herper,,When Sol Barer explained $celg iMID franchise to me in 2006. Story here:  https://t.co/FTDcbLyZ68  https://t.co/ZbwMtjJgep,en,[],['https://www.forbes.com/forbes/2006/0227/077.html#750d1b1f1b73'],['https://pbs.twimg.com/media/Du4IafWW4AATLyE.jpg'],3,2,13,[],['celg'],https://twitter.com/matthewherper/status/1075806616241483777,False,,1,https://pbs.twimg.com/media/Du4IafWW4AATLyE.jpg,,,,,,,[],,,,
1075144424282316800,1075144424282316800,2018-12-19 03:13:00 IST,2018-12-19,03:13:00,+0530,529704495,damiangarde,Damian Garde,,$surf move in cd47 comes on heels of $celg's decision back in october  https://t.co/PTsCR1RgYF,en,[],['https://www.statnews.com/2018/10/09/celgene-early-blood-cancer-trial-shuttered/'],[],1,2,9,[],"['surf', 'celg']",https://twitter.com/damiangarde/status/1075144424282316800,False,,0,,,,,,,,[],,,,
1075018617832570880,1075018617832570880,2018-12-18 18:53:06 IST,2018-12-18,18:53:06,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Leiden victorious in best biopharma CEO tally; Alles tops worst list  https://t.co/EG7qhJjPQO Your votes counted. $VRTX $CELG,en,[],['https://www.statnews.com/2018/12/18/leiden-victorious-in-best-biopharma-ceo-tally-alles-tops-worst-list/'],[],1,7,9,[],"['vrtx', 'celg']",https://twitter.com/adamfeuerstein/status/1075018617832570880,False,,0,,,,,,,,[],,,,
1073216000391286784,1073216000391286784,2018-12-13 19:30:08 IST,2018-12-13,19:30:08,+0530,102754598,johncendpts,John Carroll,,Who needs venture backers? Bill Haney bags new deal cash from Celgene as his biotech upstart Dragonfly explores NK cell tech $CELG  https://t.co/R50IA2ahqI,en,[],['https://endpts.com/who-needs-venture-backers-bill-haney-bags-new-deal-cash-from-celgene-as-his-biotech-upstart-dragonfly-explores-nk-cell-tech/'],[],1,2,6,[],['celg'],https://twitter.com/JohnCendpts/status/1073216000391286784,False,,0,,,,,,,,[],,,,
1072528832115208192,1072492149252505607,2018-12-11 21:59:34 IST,2018-12-11,21:59:34,+0530,873399943,jacobplieth,Jacob Plieth,,"Curiouser and curiouser. Yesterday Marcela Maus, now Nirali Shah, refer to manufacturing changes that might have resulted in JCAR015 toxicity $JUNO $CELG",en,[],[],[],2,1,6,[],"['juno', 'celg']",https://twitter.com/JacobPlieth/status/1072528832115208192,False,,0,,,,,,,,[],,,,
1069820960063156224,1069820960063156224,2018-12-04 10:39:27 IST,2018-12-04,10:39:27,+0530,873399943,jacobplieth,Jacob Plieth,,"Everything you wanted to know about BCMA CAR-T at #ASH18, including the deepening mystery of Nanjing Legend:  https://t.co/NogoqUyFEB $CELG $BLUE $JNJ",en,[],['http://www.evaluate.com/vantage/articles/events/conferences/ash-2018-legends-mystery-car-raises-more-questions'],[],1,22,40,['ash18'],"['celg', 'blue', 'jnj']",https://twitter.com/JacobPlieth/status/1069820960063156224,False,,0,,,,,,,,[],,,,
1069792292305690624,805399249219268608,2018-12-04 08:45:32 IST,2018-12-04,08:45:32,+0530,873399943,jacobplieth,Jacob Plieth,,"Take that, $CELG $BLUE: Poseida says BLA filing for P-BCMA-101 is due in 2020!! #ASH18  https://t.co/7R4JXrkXJs",en,[],[],"['https://pbs.twimg.com/media/DtiqajBVAAEZnvm.jpg', 'https://pbs.twimg.com/media/DtiqajbVYAALOkA.jpg']",4,5,23,['ash18'],"['celg', 'blue']",https://twitter.com/JacobPlieth/status/1069792292305690624,False,,1,https://pbs.twimg.com/media/DtiqajBVAAEZnvm.jpg,,,,,,,[],,,,
1069788325379067904,1069787591132635136,2018-12-04 08:29:47 IST,2018-12-04,08:29:47,+0530,873399943,jacobplieth,Jacob Plieth,,"FCARH143 is another (undisclosed) defined-cell CAR. N=11, all manufactured but in 2 the correct composition couldn‚Äôt be achieved #ASH18 $CELG  https://t.co/ogVLzgccdV",en,[],[],['https://pbs.twimg.com/media/Dtimz19U4AAk-Jk.jpg'],3,2,7,['ash18'],['celg'],https://twitter.com/JacobPlieth/status/1069788325379067904,False,,1,https://pbs.twimg.com/media/Dtimz19U4AAk-Jk.jpg,,,,,,,[],,,,
1069787591132635136,1069787591132635136,2018-12-04 08:26:52 IST,2018-12-04,08:26:52,+0530,873399943,jacobplieth,Jacob Plieth,,"First clinical study of FCARH143, anti-BCMA CAR derived from Seattle Children‚Äôs via Damian Green. Median lines=11 (!). $CELG #ASH18",en,[],[],[],1,5,13,['ash18'],['celg'],https://twitter.com/JacobPlieth/status/1069787591132635136,False,,0,,,,,,,,[],,,,
1069767626774085632,1069766889545457664,2018-12-04 07:07:32 IST,2018-12-04,07:07:32,+0530,873399943,jacobplieth,Jacob Plieth,,BCMA expression was required in MCARH171 study #ASH18 $CELG  https://t.co/IXHUpavvxl,en,[],[],"['https://pbs.twimg.com/media/DtiT9FoUcAY7A4Y.jpg', 'https://pbs.twimg.com/media/DtiT9FpUwAYlYpQ.jpg', 'https://pbs.twimg.com/media/DtiT9FwVYAA1bVn.jpg']",0,2,7,['ash18'],['celg'],https://twitter.com/JacobPlieth/status/1069767626774085632,False,,1,https://pbs.twimg.com/media/DtiT9FoUcAY7A4Y.jpg,,,,,,,[],,,,
1069766889545457664,1069766889545457664,2018-12-04 07:04:36 IST,2018-12-04,07:04:36,+0530,873399943,jacobplieth,Jacob Plieth,,First clinical data for MCARH171 $CELG anti-BCMA CAR derived from MSKCC via S Mailankody #ASH18  https://t.co/SG9m0sgEae,ro,[],[],"['https://pbs.twimg.com/media/DtiTUDaVYAEh-qa.jpg', 'https://pbs.twimg.com/media/DtiTUDcV4AAI2of.jpg']",2,9,17,['ash18'],['celg'],https://twitter.com/JacobPlieth/status/1069766889545457664,False,,1,https://pbs.twimg.com/media/DtiTUDaVYAEh-qa.jpg,,,,,,,[],,,,
1069760463888470016,939829476615163904,2018-12-04 06:39:04 IST,2018-12-04,06:39:04,+0530,873399943,jacobplieth,Jacob Plieth,,JCARH125 efficacy &amp; conclusion #ASH18 $CELG  https://t.co/yLFwd9aUg5,fr,[],[],"['https://pbs.twimg.com/media/DtiNcn5U8AAu3l_.jpg', 'https://pbs.twimg.com/media/DtiNcn1U8AAhVaO.jpg', 'https://pbs.twimg.com/media/DtiNcnyVAAUrjMu.jpg']",2,7,11,['ash18'],['celg'],https://twitter.com/JacobPlieth/status/1069760463888470016,False,,1,https://pbs.twimg.com/media/DtiNcn5U8AAu3l_.jpg,,,,,,,[],,,,
1069759921481076736,939829476615163904,2018-12-04 06:36:55 IST,2018-12-04,06:36:55,+0530,873399943,jacobplieth,Jacob Plieth,,1 death w gr4 CRS in JCARH125; study $CELG #ASH18  https://t.co/UuInin3dFb,pl,[],[],"['https://pbs.twimg.com/media/DtiM-TUVAAESH7G.jpg', 'https://pbs.twimg.com/media/DtiM-TSUUAAv9rh.jpg']",2,2,5,['ash18'],['celg'],https://twitter.com/JacobPlieth/status/1069759921481076736,False,,1,https://pbs.twimg.com/media/DtiM-TUVAAESH7G.jpg,,,,,,,[],,,,
1069759338116333568,939829476615163904,2018-12-04 06:34:36 IST,2018-12-04,06:34:36,+0530,873399943,jacobplieth,Jacob Plieth,,Evolve study of JCARH125 anti-BCMA CAR via S Mailankody. No requirement for BCMA expression. Bridging chemo allowed $CELG #ASH18  https://t.co/CXVfznA9zA,en,[],[],"['https://pbs.twimg.com/media/DtiMcMDVsAAkGTy.jpg', 'https://pbs.twimg.com/media/DtiMcMCV4AE8Rxk.jpg']",1,6,6,['ash18'],['celg'],https://twitter.com/JacobPlieth/status/1069759338116333568,False,,1,https://pbs.twimg.com/media/DtiMcMDVsAAkGTy.jpg,,,,,,,[],,,,
1069611316602695681,1069610264952221696,2018-12-03 20:46:24 IST,2018-12-03,20:46:24,+0530,873399943,jacobplieth,Jacob Plieth,,It‚Äôs MCARH109. Clinical trial including post-BCMA therapy patients starting Q1 2019 $CELG #ASH18  https://t.co/jhGOKfuLQK,en,[],[],['https://pbs.twimg.com/media/DtgFz9OW0AMlabR.jpg'],2,6,11,['ash18'],['celg'],https://twitter.com/JacobPlieth/status/1069611316602695681,False,,1,https://pbs.twimg.com/media/DtgFz9OW0AMlabR.jpg,,,,,,,[],,,,
1069610264952221696,1069610264952221696,2018-12-03 20:42:14 IST,2018-12-03,20:42:14,+0530,873399943,jacobplieth,Jacob Plieth,,GPRC5D as a multiple myeloma target? This is a CAR from Juno/Eureka $CELG via Eric Smith #ASH18  https://t.co/IfwDFpIvug,en,[],[],"['https://pbs.twimg.com/media/DtgE2OpX4AAakfh.jpg', 'https://pbs.twimg.com/media/DtgE2OuWkAE0qEM.jpg', 'https://pbs.twimg.com/media/DtgE2OsX4AA4tOS.jpg']",1,7,14,['ash18'],['celg'],https://twitter.com/JacobPlieth/status/1069610264952221696,False,,1,https://pbs.twimg.com/media/DtgE2OpX4AAakfh.jpg,,,,,,,[],,,,
1069590080770240512,1069585345757552640,2018-12-03 19:22:01 IST,2018-12-03,19:22:01,+0530,873399943,jacobplieth,Jacob Plieth,,"Coming from #ASH18 today: data on $CELG JCARH125, MCARH171, FCARH143, $JNJ Legend and others. This from $BLUE yesterday:  https://t.co/EEG6mBLCQh",en,[],['https://twitter.com/JacobPlieth/status/1069427289752915969'],[],0,2,6,['ash18'],"['celg', 'jnj', 'blue']",https://twitter.com/JacobPlieth/status/1069590080770240512,False,https://twitter.com/JacobPlieth/status/1069427289752915969,0,,,,,,,,[],,,,
1069427289752915969,1069427289752915969,2018-12-03 08:35:09 IST,2018-12-03,08:35:09,+0530,873399943,jacobplieth,Jacob Plieth,,"Bedtime #ASH18 reading! bb21217, the Goldilocks CAR. Via @Vantageanalysis $BLUE $CELG  https://t.co/TZtbC3bM7O",en,"[{'screen_name': 'vantageanalysis', 'name': 'evaluate vantage', 'id': '3033767986'}]",['http://bit.ly/2PgFDMv'],[],1,11,30,['ash18'],"['blue', 'celg']",https://twitter.com/JacobPlieth/status/1069427289752915969,False,,0,,,,,,,,[],,,,
1069399532079857670,1069393616945188864,2018-12-03 06:44:51 IST,2018-12-03,06:44:51,+0530,873399943,jacobplieth,Jacob Plieth,,Future dose levels in $BLUE bb21217 study $CELG #ASH18  https://t.co/CEaVS3zaIP,en,[],[],['https://pbs.twimg.com/media/DtdFMePW0AE7wOr.jpg'],0,2,8,['ash18'],"['blue', 'celg']",https://twitter.com/JacobPlieth/status/1069399532079857670,False,,1,https://pbs.twimg.com/media/DtdFMePW0AE7wOr.jpg,,,,,,,[],,,,
1069395585332125696,1069393616945188864,2018-12-03 06:29:10 IST,2018-12-03,06:29:10,+0530,873399943,jacobplieth,Jacob Plieth,,bb21217 kinetics &amp; summary $BLUE $CELG #ASH18  https://t.co/uTArxaI78X,en,[],[],"['https://pbs.twimg.com/media/DtdBm15WsAARgA8.jpg', 'https://pbs.twimg.com/media/DtdBm13XoAIHoVn.jpg']",1,3,10,['ash18'],"['blue', 'celg']",https://twitter.com/JacobPlieth/status/1069395585332125696,False,,1,https://pbs.twimg.com/media/DtdBm15WsAARgA8.jpg,,,,,,,[],,,,
1069394955389607936,1069393616945188864,2018-12-03 06:26:40 IST,2018-12-03,06:26:40,+0530,873399943,jacobplieth,Jacob Plieth,,"bb21217 150m cell cohort, ORR=83% $BLUE $CELG #ASH18  https://t.co/qhumTS5l1e",en,[],[],['https://pbs.twimg.com/media/DtdBBmUWsAAg_6Z.jpg'],2,5,8,['ash18'],"['blue', 'celg']",https://twitter.com/JacobPlieth/status/1069394955389607936,False,,1,https://pbs.twimg.com/media/DtdBBmUWsAAg_6Z.jpg,,,,,,,[],,,,
1069394420410302465,1069393616945188864,2018-12-03 06:24:32 IST,2018-12-03,06:24:32,+0530,873399943,jacobplieth,Jacob Plieth,,"bb21217 150m cell cohort only. n=12, median follow-up 26 wk $BLUE $CELG #ASH18  https://t.co/2REt3Uurol",en,[],[],['https://pbs.twimg.com/media/DtdAih_WwAAPIcb.jpg'],1,2,6,['ash18'],"['blue', 'celg']",https://twitter.com/JacobPlieth/status/1069394420410302465,False,,1,https://pbs.twimg.com/media/DtdAih_WwAAPIcb.jpg,,,,,,,[],,,,
1069393616945188864,1069393616945188864,2018-12-03 06:21:21 IST,2018-12-03,06:21:21,+0530,873399943,jacobplieth,Jacob Plieth,,bb21217 rationale via Nina Shah $BLUE $CELG #ASH18  https://t.co/Nw1RtsVlld,en,[],[],"['https://pbs.twimg.com/media/Dtc_0P1XoAA0JKw.jpg', 'https://pbs.twimg.com/media/Dtc_0P2W0AI7yKP.jpg']",1,11,16,['ash18'],"['blue', 'celg']",https://twitter.com/JacobPlieth/status/1069393616945188864,False,,1,https://pbs.twimg.com/media/Dtc_0P1XoAA0JKw.jpg,,,,,,,[],,,,
1069388516138860545,1069388516138860545,2018-12-03 06:01:05 IST,2018-12-03,06:01:05,+0530,102754598,johncendpts,John Carroll,,"New #ASH18: Bluebird and Celgene didn‚Äôt ‚Äúbreak‚Äù their next-gen BCMA CAR-T, so now they‚Äôll double down on the dose and root for real durability $BLUE $CELG  https://t.co/SgzyDu4Wwi",en,[],['https://endpts.com/ash18-bluebird-and-celgene-didnt-break-their-next-gen-bcma-car-t-so-now-theyll-double-down-on-the-dose-and-root-for-real-durability/'],[],0,7,10,['ash18'],"['blue', 'celg']",https://twitter.com/JohnCendpts/status/1069388516138860545,False,,0,,,,,,,,[],,,,
1069355017688223744,1069355017688223744,2018-12-03 03:47:58 IST,2018-12-03,03:47:58,+0530,102754598,johncendpts,John Carroll,,"#ASH18 is big for $CELG -- too bad they seem incapable of making a case for themselves. Lame is one thing, shooting yourself in the foot is another.",en,[],[],[],2,1,6,['ash18'],['celg'],https://twitter.com/JohnCendpts/status/1069355017688223744,False,,0,,,,,,,,[],,,,
1069309686070030338,1069309686070030338,2018-12-03 00:47:50 IST,2018-12-03,00:47:50,+0530,873399943,jacobplieth,Jacob Plieth,,Under $CELG the JCAR017 development plan is shifting. Via @Vantageanalysis  https://t.co/lGJcppibfT #ASH18,en,"[{'screen_name': 'vantageanalysis', 'name': 'evaluate vantage', 'id': '3033767986'}]",['http://bit.ly/2BMEQzI'],[],4,13,27,['ash18'],['celg'],https://twitter.com/JacobPlieth/status/1069309686070030338,False,,0,,,,,,,,[],,,,
1069274441048297472,1069274441048297472,2018-12-02 22:27:47 IST,2018-12-02,22:27:47,+0530,873399943,jacobplieth,Jacob Plieth,,Transcend-CLL study of JCAR017 post Imbruvica. 13/16 got bridging therapy. Via T Siddiqi $CELG #ASH18  https://t.co/Ar9SlI28VO,en,[],[],['https://pbs.twimg.com/media/DtbTa5wXQAAbGJU.jpg'],1,2,8,['ash18'],['celg'],https://twitter.com/JacobPlieth/status/1069274441048297472,False,,1,https://pbs.twimg.com/media/DtbTa5wXQAAbGJU.jpg,,,,,,,[],,,,
1069025913667342336,871482431177723905,2018-12-02 06:00:14 IST,2018-12-02,06:00:14,+0530,873399943,jacobplieth,Jacob Plieth,,"Safety data with MSKCC auto/trans co-stimulated CD19 armored CAR, via J Park. Impressive! #ASH18 $CELG  https://t.co/X5M7Qv7tsv",en,[],[],"['https://pbs.twimg.com/media/DtXxGHsVsAMoqu0.jpg', 'https://pbs.twimg.com/media/DtXxGHtUwAIYBaS.jpg']",1,10,20,['ash18'],['celg'],https://twitter.com/JacobPlieth/status/1069025913667342336,False,,1,https://pbs.twimg.com/media/DtXxGHsVsAMoqu0.jpg,,,,,,,[],,,,
1069024695180124161,871482431177723905,2018-12-02 05:55:23 IST,2018-12-02,05:55:23,+0530,873399943,jacobplieth,Jacob Plieth,,"First human data with MSKCC auto/trans co-stimulated CD19 armored CAR, via J Park #ASH18 $CELG  https://t.co/I9uc8Fqb2r",en,[],[],['https://pbs.twimg.com/media/DtXwFTXU8AIrnv8.jpg'],4,14,21,['ash18'],['celg'],https://twitter.com/JacobPlieth/status/1069024695180124161,False,,1,https://pbs.twimg.com/media/DtXwFTXU8AIrnv8.jpg,,,,,,,[],,,,
1068957384192622592,1068957384192622592,2018-12-02 01:27:55 IST,2018-12-02,01:27:55,+0530,873399943,jacobplieth,Jacob Plieth,,"JCAR014 +/- Imbruvica in CLL, via @drjgauthier No severe CRS in Imbruvica concurrent cohort; 1 death in each $CELG #ASH18  https://t.co/Z4J8BFdyfB",en,"[{'screen_name': 'drjgauthier', 'name': 'jordan gauthier', 'id': '4466075238'}]",[],"['https://pbs.twimg.com/media/DtWy_4CUwAA_Iv_.jpg', 'https://pbs.twimg.com/media/DtWy_3dUwAAukIx.jpg', 'https://pbs.twimg.com/media/DtWy_3dVsAA2pt_.jpg']",3,16,24,['ash18'],['celg'],https://twitter.com/JacobPlieth/status/1068957384192622592,False,,1,https://pbs.twimg.com/media/DtWy_4CUwAA_Iv_.jpg,,,,,,,[],,,,
1067753232666112000,1067753232666112000,2018-11-28 17:43:03 IST,2018-11-28,17:43:03,+0530,873399943,jacobplieth,Jacob Plieth,,Anyone surprised that the sum total of JCAR017's registrational (?) Transcend data at #ASH18 is a single poster? $CELG,en,[],[],[],2,3,6,['ash18'],['celg'],https://twitter.com/JacobPlieth/status/1067753232666112000,False,,0,,,,,,,,[],,,,
1067397572791283712,1067397572791283712,2018-11-27 18:09:47 IST,2018-11-27,18:09:47,+0530,102094857,adamfeuerstein,Adam Feuerstein,,‚ÄúThe FDA action date for the bb2121 NDA is anticipated in 2020.‚Äù  That‚Äôs a bold (rather odd) statement to include in a PR about completing patient enrollment in a pivotal trial. No results yet. $CELG $BLUE  https://t.co/dsm23l19XN,en,[],[],['https://pbs.twimg.com/media/DtAoXM8UwAEioUg.jpg'],2,6,8,[],"['celg', 'blue']",https://twitter.com/adamfeuerstein/status/1067397572791283712,False,,1,https://pbs.twimg.com/media/DtAoXM8UwAEioUg.jpg,,,,,,,[],,,,
1064494392990408704,1064494392990408704,2018-11-19 17:53:35 IST,2018-11-19,17:53:35,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"A Chinese CAR-T company got the world‚Äôs attention with early data. At #ASH18, it has questions to answer  https://t.co/XaDGcCDO37 via @rebeccadrobbins $JNJ $CELG $BLUE $AMGN",en,"[{'screen_name': 'rebeccadrobbins', 'name': 'rebecca robbins', 'id': '368158573'}]",['https://www.statnews.com/2018/11/19/a-chinese-car-t-company-got-the-worlds-attention-with-early-data-at-ash-it-has-questions-to-answer/'],[],0,10,18,['ash18'],"['jnj', 'celg', 'blue', 'amgn']",https://twitter.com/adamfeuerstein/status/1064494392990408704,False,,0,,,,,,,,[],,,,
1062803817220186118,1062803817220186118,2018-11-15 01:55:50 IST,2018-11-15,01:55:50,+0530,102754598,johncendpts,John Carroll,,"#2 Celgene doubles down on Dragonfly‚Äôs natural killer tech, expanding into solid tumors with an injection of ‚Äòamplification capital‚Äô $CELG  https://t.co/c1ztF7CpyF",en,[],['https://endpts.com/celgene-doubles-down-on-dragonflys-natural-killer-tech-expanding-into-solid-tumors/'],[],0,5,9,[],['celg'],https://twitter.com/JohnCendpts/status/1062803817220186118,False,,0,,,,,,,,[],,,,
1062691925642358784,1062691925642358784,2018-11-14 18:31:13 IST,2018-11-14,18:31:13,+0530,102754598,johncendpts,John Carroll,,"Celgene doubles down on Dragonfly‚Äôs natural killer tech, expanding into solid tumors $CELG  https://t.co/c1ztF7CpyF",en,[],['https://endpts.com/celgene-doubles-down-on-dragonflys-natural-killer-tech-expanding-into-solid-tumors/'],[],0,5,10,[],['celg'],https://twitter.com/JohnCendpts/status/1062691925642358784,False,,0,,,,,,,,[],,,,
1059991353650765824,1059991353650765824,2018-11-07 07:40:07 IST,2018-11-07,07:40:07,+0530,44438256,matthewherper,Matthew Herper,,And that means that former $CELG chairman Robert Hugin did not win his race.,en,[],[],[],5,4,8,[],['celg'],https://twitter.com/matthewherper/status/1059991353650765824,False,https://twitter.com/AP/status/1059989775606861824,0,,,,,,,,[],,,,
1058024793344274432,1058024793344274432,2018-11-01 21:25:42 IST,2018-11-01,21:25:42,+0530,47678782,megtirrell,Meg Tirrell,,"A few #ASH18 movers: $CELG +5% $BLUE +8.7% $ONCE +7.5% $BMRN +5.9% $MGTA -7.3% Helping boost $IBB, which lost almost 15% in October, by 2.9% today. $XBI +4.4%",en,[],[],[],6,8,19,['ash18'],"['celg', 'blue', 'once', 'bmrn', 'mgta', 'ibb', 'xbi']",https://twitter.com/megtirrell/status/1058024793344274432,False,,0,,,,,,,,[],,,,
1057997275430076418,1057997275430076418,2018-11-01 19:36:21 IST,2018-11-01,19:36:21,+0530,16732770,cnbcfastmoney,CNBC's Fast Money,,$CELG up more than 3% today!,en,[],[],[],3,3,13,[],['celg'],https://twitter.com/CNBCFastMoney/status/1057997275430076418,False,https://twitter.com/CNBCFastMoney/status/1057752108475314176,0,,,,,,,,[],,,,
1057983402685685760,1057983402685685760,2018-11-01 18:41:14 IST,2018-11-01,18:41:14,+0530,873399943,jacobplieth,Jacob Plieth,,Transcend update #ASH18  https://t.co/powDhuKpIl $CELG $JUNO,en,[],['http://bit.ly/2AFzp4J'],[],0,3,9,['ash18'],"['celg', 'juno']",https://twitter.com/JacobPlieth/status/1057983402685685760,False,,0,,,,,,,,[],,,,
1057752108475314176,1057752108475314176,2018-11-01 03:22:09 IST,2018-11-01,03:22:09,+0530,16732770,cnbcfastmoney,CNBC's Fast Money,,"Biotech got battered this month, but @petenajarian is betting on a bounce for one stock: Celgene. $CELG  https://t.co/qhxAg0DEPZ",en,"[{'screen_name': 'petenajarian', 'name': 'pete najarian', 'id': '14292717'}]",[],[],6,15,53,[],['celg'],https://twitter.com/CNBCFastMoney/status/1057752108475314176,False,,1,https://pbs.twimg.com/media/Dq3j61SWwAAB39I.jpg,,,,,,,[],,,,
1057750484742795265,1057750484742795265,2018-11-01 03:15:42 IST,2018-11-01,03:15:42,+0530,16732770,cnbcfastmoney,CNBC's Fast Money,,POLL: Are you buying @petenajarian's Fast Pitch for $CELG?,en,"[{'screen_name': 'petenajarian', 'name': 'pete najarian', 'id': '14292717'}]",[],[],18,2,15,[],['celg'],https://twitter.com/CNBCFastMoney/status/1057750484742795265,False,,0,,,,,,,,[],,,,
1055534463210479616,1055534463210479616,2018-10-26 00:30:01 IST,2018-10-26,00:30:01,+0530,16451932,madmoneyoncnbc,Mad Money On CNBC,,"This stock may look like it's under the weather, but like any cold, @JimCramer says you've just got to ride this one out $CELG  https://t.co/fo3mliUKUk",en,"[{'screen_name': 'jimcramer', 'name': 'jim cramer', 'id': '14216123'}]",[],[],2,6,22,[],['celg'],https://twitter.com/MadMoneyOnCNBC/status/1055534463210479616,False,,1,https://pbs.twimg.com/amplify_video_thumb/1055526113554898946/img/SskfFrrlYmqlcbHT.jpg,,,,,,,[],,,,
1055138164069883905,1055138164069883905,2018-10-24 22:15:16 IST,2018-10-24,22:15:16,+0530,15568127,themotleyfool,The Motley Fool,,"Based on forward P/E, these stocks look like wild bargains. Guess the real question is, do you believe the forecasts? $CELG $WHR $BAC $T $IBM  https://t.co/cBcSBeUPfi",en,[],['https://www.fool.com/investing/2018/10/23/5-deeply-discounted-value-stocks-that-havent-been.aspx'],[],3,5,21,[],"['celg', 'whr', 'bac', 't', 'ibm']",https://twitter.com/themotleyfool/status/1055138164069883905,False,,0,,,,,,,,[],,,,
1055083418550198272,1055078907748278273,2018-10-24 18:37:44 IST,2018-10-24,18:37:44,+0530,873399943,jacobplieth,Jacob Plieth,,"But seriously, that $JUNO brewery shutdown story isn't accurate. $CELG has actually sold the brewery biz back to Hans, who is IPO'ing it next month",en,[],[],[],1,0,15,[],"['juno', 'celg']",https://twitter.com/JacobPlieth/status/1055083418550198272,False,,0,,,,,,,,[],,,,
1055078907748278273,1055078907748278273,2018-10-24 18:19:48 IST,2018-10-24,18:19:48,+0530,873399943,jacobplieth,Jacob Plieth,,"Important message for $JUNO employees suffering ""integration"" issues at $CELG  https://t.co/u2n9Mm1Ffr",en,[],['https://www.youtube.com/watch?v=qCW-SVPCw4Y'],[],2,0,10,[],"['juno', 'celg']",https://twitter.com/JacobPlieth/status/1055078907748278273,False,,0,,,,,,,,[],,,,
1054101264596819970,1054101264596819970,2018-10-22 01:35:00 IST,2018-10-22,01:35:00,+0530,274233761,bradloncar,Brad Loncar,,Important week of earnings coming up.  M: $IQV T: $ALKS $BIIB $ILMN W: $ALXN $SRPT $VRTX T: $BMY $CELG $GILD $MRK F: $ZBH  The full schedule:  https://t.co/HUDBDpBplJ  https://t.co/YzL4fSQats,en,[],['https://www.loncarblog.com/october-15-earnings'],['https://pbs.twimg.com/media/Dp7E80kUwAE4G1s.jpg'],1,8,22,[],"['iqv', 'alks', 'biib', 'ilmn', 'alxn', 'srpt', 'vrtx', 'bmy', 'celg', 'gild', 'mrk', 'zbh']",https://twitter.com/bradloncar/status/1054101264596819970,False,,1,https://pbs.twimg.com/media/Dp7E80kUwAE4G1s.jpg,,,,,,,[],,,,
1052946717505716225,1052946717505716225,2018-10-18 21:07:14 IST,2018-10-18,21:07:14,+0530,15563814,loftus,Peter Loftus,,CEOs of $AGN $ABT $ESRX $CELG $PFE $AMGN $LLY $MRK $REGN spending on midterms...,en,[],[],[],2,9,8,[],"['agn', 'abt', 'esrx', 'celg', 'pfe', 'amgn', 'lly', 'mrk', 'regn']",https://twitter.com/Loftus/status/1052946717505716225,False,https://twitter.com/OpenSecretsDC/status/1052944895248347137,0,,,,,,,,[],,,,
1051899326933454848,1051899326933454848,2018-10-15 23:45:17 IST,2018-10-15,23:45:17,+0530,15568127,themotleyfool,The Motley Fool,,"The Fool philosophy is to buy excellence any time and hold it long term, not to market-time. But seriously, who doesn‚Äôt love a bargain? $SIRI $WHR $CELG $PM $AMZN  https://t.co/MveVXEEZiE",en,[],['https://www.fool.com/investing/2018/10/12/5-stocks-to-absolutely-love-during-this-correction.aspx'],[],1,10,23,[],"['siri', 'whr', 'celg', 'pm', 'amzn']",https://twitter.com/themotleyfool/status/1051899326933454848,False,,0,,,,,,,,[],,,,
1050485719238696960,1050485719238696960,2018-10-12 02:08:07 IST,2018-10-12,02:08:07,+0530,368158573,rebeccadrobbins,Rebecca Robbins,,"We have a new episode of our biotech podcast out for you! We ask: üîπ Is the next big idea in oncology a bust? (ft. $CELG and CD47) üîπ What does ‚Äúsuccessful‚Äù mean, exactly? (ft. $TRVN) üîπ What's on the cutting edge of fertility medicine? (ft. @dbsable)  https://t.co/ITIqDeru9p",en,"[{'screen_name': 'dbsable', 'name': 'david sable', 'id': '86125016'}]",['https://www.statnews.com/2018/10/11/podcast-trevana-fda-cancer-biotech/'],[],2,2,9,[],"['celg', 'trvn']",https://twitter.com/RebeccaDRobbins/status/1050485719238696960,False,,0,,,,,,,,[],,,,
1050039083140042752,1050039083140042752,2018-10-10 20:33:20 IST,2018-10-10,20:33:20,+0530,873399943,jacobplieth,Jacob Plieth,,"A look at recent CD47 developments before $CELG's bobmshell, via @Vantageanalysis  https://t.co/nmF3RTipUv $TRIL $FTSV $SURF $TGTX",en,"[{'screen_name': 'vantageanalysis', 'name': 'evaluate vantage', 'id': '3033767986'}]",['http://bit.ly/2OS2MJ4'],[],5,12,15,[],"['celg', 'tril', 'ftsv', 'surf', 'tgtx']",https://twitter.com/JacobPlieth/status/1050039083140042752,False,,0,,,,,,,,[],,,,
1047581032462077953,1047581032462077953,2018-10-04 01:45:55 IST,2018-10-04,01:45:55,+0530,14292717,petenajarian,Pete Najarian,,$CELG calls triple in three days  https://t.co/x7M0wOdttj via investitute,en,[],['http://zpr.io/6wrmP'],[],0,3,11,[],['celg'],https://twitter.com/petenajarian/status/1047581032462077953,False,,0,,,,,,,,[],,,,
1046729282142261248,1046729282142261248,2018-10-01 17:21:22 IST,2018-10-01,17:21:22,+0530,20653467,ossingerj,Joanna Ossinger,,Goldman says these 33 U.S. #stocks can withstand #tariffs turmoil  https://t.co/LwcUDi4QLb via @markets $KO $SIRI $EXPE $AMGN $CELG $VMW,en,"[{'screen_name': 'markets', 'name': 'bloomberg markets', 'id': '69620713'}]",['https://www.bloomberg.com/news/articles/2018-10-01/goldman-says-these-33-u-s-stocks-can-withstand-tariff-turmoil'],[],0,11,23,"['stocks', 'tariffs']","['ko', 'siri', 'expe', 'amgn', 'celg', 'vmw']",https://twitter.com/ossingerj/status/1046729282142261248,False,,0,,,,,,,,[],,,,
1039803599231037440,1039803599231037440,2018-09-12 14:41:11 IST,2018-09-12,14:41:11,+0530,102754598,johncendpts,John Carroll,,"And this -- Bristol-Myers claims the lead in a race to develop a TYK2 drug, hoping to disrupt a huge market for anti-inflammatories $BMY $CELG $PFE  https://t.co/MO5U05MLrR",en,[],['https://endpts.com/bristol-myers-claims-the-lead-in-a-race-to-develop-a-tyk2-drug-hoping-to-disrupt-a-huge-market-for-anti-inflammatories/'],[],1,3,10,[],"['bmy', 'celg', 'pfe']",https://twitter.com/JohnCendpts/status/1039803599231037440,False,,0,,,,,,,,[],,,,
1039789016449802240,1039789016449802240,2018-09-12 13:43:14 IST,2018-09-12,13:43:14,+0530,102754598,johncendpts,John Carroll,,"Bristol-Myers claims the lead in a race to develop a TYK2 drug, hoping to disrupt a huge market for anti-inflammatories $BMY $PFE $CELG  https://t.co/MO5U05MLrR",en,[],['https://endpts.com/bristol-myers-claims-the-lead-in-a-race-to-develop-a-tyk2-drug-hoping-to-disrupt-a-huge-market-for-anti-inflammatories/'],[],0,9,15,[],"['bmy', 'pfe', 'celg']",https://twitter.com/JohnCendpts/status/1039789016449802240,False,,0,,,,,,,,[],,,,
1039238970989838341,1039238970989838341,2018-09-11 01:17:33 IST,2018-09-11,01:17:33,+0530,102754598,johncendpts,John Carroll,,"This is mostly another ding for $GSK -- Analyst offers Amgen a boost for its rival anti-BCMA BiTE, blemishing GSK as well as CAR-T rivals Celgene and bluebird $AMGN $CELG $BLUE  https://t.co/os0sokZFA9",en,[],['https://endpts.com/?p=168199&preview=true'],[],3,6,14,[],"['gsk', 'amgn', 'celg', 'blue']",https://twitter.com/JohnCendpts/status/1039238970989838341,False,,0,,,,,,,,[],,,,
1039216664309624835,1039216664309624835,2018-09-10 23:48:55 IST,2018-09-10,23:48:55,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$AMGN emerges as new multiple myeloma drug player, threatening $BLUE $CELG  https://t.co/gP8LdPxcx3 BiTE vs CAR-T",en,[],['https://www.statnews.com/2018/09/10/amgen-emerges-as-new-multiple-myeloma-drug-player-threatening-bluebird-celgene/'],[],6,9,31,[],"['amgn', 'blue', 'celg']",https://twitter.com/adamfeuerstein/status/1039216664309624835,False,,0,,,,,,,,[],,,,
1037661888681787392,1037661888681787392,2018-09-06 16:50:47 IST,2018-09-06,16:50:47,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"There are no ‚ÄúCongrats on the great quarter‚Äù platitudes on the campaign trail for a NJ Senate seat. @damiangarde spent Labor Day w. former $CELG exec Bob Hugin to see how he‚Äôs fitting in to his new, less comfy, political life.   https://t.co/TXNf33nec5",en,"[{'screen_name': 'damiangarde', 'name': 'damian garde', 'id': '529704495'}]",['https://www.statnews.com/2018/09/06/bob-hugin-reinvention-new-jersey-senate/'],[],0,2,4,[],['celg'],https://twitter.com/adamfeuerstein/status/1037661888681787392,False,,0,,,,,,,,[],,,,
1035263527269879808,1035263527269879808,2018-08-31 02:00:33 IST,2018-08-31,02:00:33,+0530,15568127,themotleyfool,The Motley Fool,,Celgene's price-to-sales and price-to-earnings ratios are near the lowest they‚Äôve been since 2012. Bargain price? $CELG  https://t.co/anOmUeKioM,en,[],['https://www.fool.com/investing/2018/08/29/3-top-healthcare-stocks-to-buy-right-now.aspx'],[],0,0,9,[],['celg'],https://twitter.com/themotleyfool/status/1035263527269879808,False,,0,,,,,,,,[],,,,
1033041417852071937,1033041417852071937,2018-08-24 22:50:41 IST,2018-08-24,22:50:41,+0530,1278852289,tradingnation,Trading Nation,,"The S&amp;P 500 may be at records, but one-fifth of its components are still in a bear market. Stocks like $PM $TWTR $AAL $MU and $CELG are among those still down more than 20% from 52-week highs.  https://t.co/s48DZkQBEB",en,[],[],['https://pbs.twimg.com/media/DlYWsmZXsAAZfmT.jpg'],6,9,17,[],"['pm', 'twtr', 'aal', 'mu', 'celg']",https://twitter.com/TradingNation/status/1033041417852071937,False,,1,https://pbs.twimg.com/media/DlYWsmZXsAAZfmT.jpg,,,,,,,[],,,,
1027598152935919619,1027598152935919619,2018-08-09 22:21:06 IST,2018-08-09,22:21:06,+0530,14886375,stocktwits,Stocktwits,,"Here's a list of 27 stocks going after cancer. Including the big names like $CELG, $GILD, $PFE, and $MRK. And then several stocks you've probably never heard of. üí™   https://t.co/whcgaCb6BO",en,[],['https://stocktwits.com/discover/lists/184/the-companies-going-after-cancer'],[],1,15,28,[],"['celg', 'gild', 'pfe', 'mrk']",https://twitter.com/Stocktwits/status/1027598152935919619,False,,0,,,,,,,,[],,,,
1027297386979385364,1027297386979385364,2018-08-09 02:25:57 IST,2018-08-09,02:25:57,+0530,14115408,jonnajarian,Jon Najarian,,Pete Najarian Sees Unusual Option Activity in $CELG &amp; $DVN from investitute  https://t.co/MIWQEwisbl,in,[],['http://zpr.io/6my96'],[],2,3,12,[],"['celg', 'dvn']",https://twitter.com/jonnajarian/status/1027297386979385364,False,,0,,,,,,,,[],,,,
1027297016282603524,1027297016282603524,2018-08-09 02:24:29 IST,2018-08-09,02:24:29,+0530,14292717,petenajarian,Pete Najarian,,Pete Najarian Sees Unusual Option Activity in $CELG &amp; $DVN  https://t.co/HbY4pdoxX3 via investitute,in,[],['http://zpr.io/6my96'],[],0,2,10,[],"['celg', 'dvn']",https://twitter.com/petenajarian/status/1027297016282603524,False,,0,,,,,,,,[],,,,
1027211154811236352,1027211154811236352,2018-08-08 20:43:18 IST,2018-08-08,20:43:18,+0530,42589787,newsquawk,Newsquawk,,"Oh, @elonmusk... what have you done?! $TSLA $CELG  https://t.co/YxVCUcQFLe",en,"[{'screen_name': 'elonmusk', 'name': 'elon musk', 'id': '44196397'}]",[],['https://pbs.twimg.com/media/DkFis_MXsAAnsm8.jpg'],2,30,68,[],"['tsla', 'celg']",https://twitter.com/Newsquawk/status/1027211154811236352,False,,1,https://pbs.twimg.com/media/DkFis_MXsAAnsm8.jpg,,,,,,,[],,,,
1025140474632445959,1025140474632445959,2018-08-03 03:35:09 IST,2018-08-03,03:35:09,+0530,14886375,stocktwits,Stocktwits,,"If you missed the markets today, don't worry.  Catch up in minutes with this.  Apple $AAPL hit $1 trillion, Tesla $TSLA spiked 16%, Biotechs like $CELG are bouncing, and no one is watching the $IHI ETF.   https://t.co/jDEDXiFb7w",en,[],['https://buff.ly/2ve1iOn'],[],1,8,21,[],"['aapl', 'tsla', 'celg', 'ihi']",https://twitter.com/Stocktwits/status/1025140474632445959,False,,0,,,,,,,,[],,,,
1024268438632419333,1024268438632419333,2018-07-31 17:50:00 IST,2018-07-31,17:50:00,+0530,368158573,rebeccadrobbins,Rebecca Robbins,,"Here's what one biopharma VC told me: You can count manufacturing experts in cellular and gene therapy on one or two hands. A few are being held onto for dear life by $GILD, $NVS, and $CELG. And a couple others are on a beach somewhere. My story:  https://t.co/43ARs4j7nA  https://t.co/gyAoWrKCSl",en,[],['https://www.statnews.com/2018/07/31/cell-gene-therapy-expert-shortage/'],['https://pbs.twimg.com/media/Dja3MXcUwAE7upc.jpg'],1,14,23,[],"['gild', 'nvs', 'celg']",https://twitter.com/RebeccaDRobbins/status/1024268438632419333,False,,1,https://pbs.twimg.com/media/Dja3MXcUwAE7upc.jpg,,,,,,,[],,,,
1022433665312337926,1022433665312337926,2018-07-26 16:19:16 IST,2018-07-26,16:19:16,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$BIIB $GILD $VRTX now $ALXN all solid Q2 earnings. Q2 is supposed to be strong but still nice to see them actually deliver. $CELG on deck.,en,[],[],[],0,3,21,[],"['biib', 'gild', 'vrtx', 'alxn', 'celg']",https://twitter.com/adamfeuerstein/status/1022433665312337926,False,,0,,,,,,,,[],,,,
1021452600108027909,1021452600108027909,2018-07-23 23:20:52 IST,2018-07-23,23:20:52,+0530,102754598,johncendpts,John Carroll,,"The big 10 of biopharma disaster reporting: Top 10 pipeline blowups, setbacks and snafus in H1 2018 $INCY, $ABBV, $CELG and more  https://t.co/QVGLCQPV3W",en,[],['https://endpts.com/top-10-pipeline-blowups-setbacks-and-snafus-in-h1-2018/'],[],0,8,9,[],"['incy', 'abbv', 'celg']",https://twitter.com/JohnCendpts/status/1021452600108027909,False,,0,,,,,,,,[],,,,
1021080683429572609,1021080683429572609,2018-07-22 22:43:00 IST,2018-07-22,22:43:00,+0530,274233761,bradloncar,Brad Loncar,,Huge week ahead. A link to the full earnings schedule is below.  M: $VCYT T: $BIIB $LLY W: $GILD $GSK $VRTX T: $AMGN $AZN $BMY $CELG F: $ABBV $HCM $MRK  The full schedule:  https://t.co/rn6VLD5Ugc  https://t.co/hd6jr5SaX2,en,[],['http://www.loncarblog.com/july-23-earnings'],['https://pbs.twimg.com/media/Diq2C27U0AA4OxO.jpg'],2,17,37,[],"['vcyt', 'biib', 'lly', 'gild', 'gsk', 'vrtx', 'amgn', 'azn', 'bmy', 'celg', 'abbv', 'hcm', 'mrk']",https://twitter.com/bradloncar/status/1021080683429572609,False,,1,https://pbs.twimg.com/media/Diq2C27U0AA4OxO.jpg,,,,,,,[],,,,
1017508006165131265,1017508006165131265,2018-07-13 02:06:27 IST,2018-07-13,02:06:27,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$BLUE $CELG make changes to BB2121 pivotal study.  https://t.co/EbtvMNzbtH,en,[],['https://www.sec.gov/Archives/edgar/data/1293971/000156459018016804/blue-8k_20180712.htm'],[],4,8,16,[],"['blue', 'celg']",https://twitter.com/adamfeuerstein/status/1017508006165131265,False,,0,,,,,,,,[],,,,
1017380537638490112,1017380537638490112,2018-07-12 17:39:56 IST,2018-07-12,17:39:56,+0530,102094857,adamfeuerstein,Adam Feuerstein,,More good $CELG news relayed via Evercore‚Äôs Umer Rafat: Ozanimod (if approved) will not have to launch vs. a generic Gilenya now that some $NVS patents were upheld in IPR process.,en,[],[],[],1,9,24,[],"['celg', 'nvs']",https://twitter.com/adamfeuerstein/status/1017380537638490112,False,,0,,,,,,,,[],,,,
1017038640327872512,1017038640327872512,2018-07-11 19:01:22 IST,2018-07-11,19:01:22,+0530,16838276,philstockworld,Phil Davis,,Philstockworld July Top Trade Review $AAPL $IBM $SPY $WSM $TGT $GILD $CELG #TradeIdeas --  https://t.co/pZ489Fw6KK  https://t.co/qpUd7bBzOm,en,[],['https://www.philstockworld.com/2018/07/11/philstockworld-july-top-trade-review/'],['https://pbs.twimg.com/media/Dh0_OpgWsAAvypn.jpg'],0,0,12,['tradeideas'],"['aapl', 'ibm', 'spy', 'wsm', 'tgt', 'gild', 'celg']",https://twitter.com/philstockworld/status/1017038640327872512,False,,1,https://pbs.twimg.com/media/Dh0_OpgWsAAvypn.jpg,,,,,,,[],,,,
1016868456124305409,1016868456124305409,2018-07-11 07:45:07 IST,2018-07-11,07:45:07,+0530,47678782,megtirrell,Meg Tirrell,,So... is the president going to call every drug company that's raised prices recently and ask them to reverse? $PFE $CELG  https://t.co/lWTQSKR2cG,en,[],['https://twitter.com/megtirrell/status/1016769284025016320'],[],18,17,69,[],"['pfe', 'celg']",https://twitter.com/megtirrell/status/1016868456124305409,False,https://twitter.com/megtirrell/status/1016769284025016320,0,,,,,,,,[],,,,
1016769284025016320,1016769284025016320,2018-07-11 01:11:02 IST,2018-07-11,01:11:02,+0530,47678782,megtirrell,Meg Tirrell,,"In today‚Äôs drug price increases, $CELG raised prices of cancer drugs Revlimid and Pomalyst by 5%, per PiperJaffray  https://t.co/9hUDeewPdV",en,[],[],['https://pbs.twimg.com/media/DhxKRnNW0AA2k7G.jpg'],5,30,27,[],['celg'],https://twitter.com/megtirrell/status/1016769284025016320,False,,1,https://pbs.twimg.com/media/DhxKRnNW0AA2k7G.jpg,,,,,,,[],,,,
1016722847287431169,1016722847287431169,2018-07-10 22:06:31 IST,2018-07-10,22:06:31,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$CELG is perking up. Here‚Äôs what needs to happen for the momentum to continue  https://t.co/YN0RHRvO87,en,[],['https://www.statnews.com/2018/07/10/celgene-is-perking-up-what-next/'],[],0,1,11,[],['celg'],https://twitter.com/adamfeuerstein/status/1016722847287431169,False,,0,,,,,,,,[],,,,
1016648195923996672,1016648195923996672,2018-07-10 17:09:52 IST,2018-07-10,17:09:52,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Roche announced this news on July 2.   Is this a $CELG version of ICYMI?  https://t.co/xnvx0t1M3R,en,[],['https://twitter.com/BioStocks/status/1016647227924606979'],[],3,4,13,[],['celg'],https://twitter.com/adamfeuerstein/status/1016648195923996672,False,https://twitter.com/BioStocks/status/1016647227924606979,0,,,,,,,,[],,,,
1016434650531680256,1016434650531680256,2018-07-10 03:01:19 IST,2018-07-10,03:01:19,+0530,102754598,johncendpts,John Carroll,,A 7-year-old alliance between Celgene and Acceleron is paying off with more promising PhIII data $CELG $XLRN  https://t.co/xKIYkaWgYh,en,[],['https://endpts.com/acceleron-and-celgene-score-in-second-phiii-study-of-anemia-drug-luspatercept/'],[],0,7,17,[],"['celg', 'xlrn']",https://twitter.com/JohnCendpts/status/1016434650531680256,False,,0,,,,,,,,[],,,,
1016413045399093250,1016413045399093250,2018-07-10 01:35:28 IST,2018-07-10,01:35:28,+0530,201891203,sanglucci,SangLucci‚Ñ¢,,Here are just a couple of the gains from today in the Steamroom $AMZN $SNAP $TWTR $BABA $CELG  https://t.co/RY9H3PnHTG,en,[],[],['https://pbs.twimg.com/media/DhsFPuDVMAUcKg6.jpg'],1,3,16,[],"['amzn', 'snap', 'twtr', 'baba', 'celg']",https://twitter.com/sanglucci/status/1016413045399093250,False,,1,https://pbs.twimg.com/media/DhsFPuDVMAUcKg6.jpg,,,,,,,[],,,,
1016115525523406849,1016115525523406849,2018-07-09 05:53:14 IST,2018-07-09,05:53:14,+0530,100024370,ophirgottlieb,Ophir Gottlieb,,"$CELG Over 5-yrs has only gapped up 5% or more off of earnings _twice_.  Owning a call for the two-weeks _after_ that, has done this:   Be. Powerful.   https://t.co/rAuh9sE9pH  https://t.co/jLyw02hUWh",en,[],['http://bit.ly/TM_Pro'],['https://pbs.twimg.com/media/Dhn3rdEU8AAJv8k.jpg'],0,3,10,[],['celg'],https://twitter.com/OphirGottlieb/status/1016115525523406849,False,,1,https://pbs.twimg.com/media/Dhn3rdEU8AAJv8k.jpg,,,,,,,[],,,,
1015334627492364296,1015334627492364296,2018-07-07 02:10:13 IST,2018-07-07,02:10:13,+0530,14292717,petenajarian,Pete Najarian,,"Into the weekend, a short list of Names not FANG that traded up over 1%: $AAPL, $MSFT, $INTC, $AMD, $TWTR, $GILD, $MCD, $BIIB, $FCX, $BIDU, $CELG, $DISH, $AMGN",en,[],[],[],7,2,31,[],"['aapl', 'msft', 'intc', 'amd', 'twtr', 'gild', 'mcd', 'biib', 'fcx', 'bidu', 'celg', 'dish', 'amgn']",https://twitter.com/petenajarian/status/1015334627492364296,False,,0,,,,,,,,[],,,,
1012728144065802240,1012728144065802240,2018-06-29 21:32:59 IST,2018-06-29,21:32:59,+0530,14292717,petenajarian,Pete Najarian,,"Off @HalftimeReport for the extra long weekend, quick take,#GiddyUp Energy rollin, $XOM, $CVX, $DVN Biotech rockin, $CELG, $BIIB, $AMGN Of course $NKE breakout stands out,  VIX- under 15",en,"[{'screen_name': 'halftimereport', 'name': 'cnbc halftime report', 'id': '234905402'}]",[],[],1,0,11,['giddyup'],"['xom', 'cvx', 'dvn', 'celg', 'biib', 'amgn', 'nke']",https://twitter.com/petenajarian/status/1012728144065802240,False,,0,,,,,,,,[],,,,
1012452458679930880,1012452458679930880,2018-06-29 03:17:31 IST,2018-06-29,03:17:31,+0530,102754598,johncendpts,John Carroll,,"Not every bad thing you hear about $CELG these days is accurate. Biotechs will still happily line up to do development deals with CELG. Their R&amp;D teams are excellent. Their money is good. They haven't handled setbacks well, and that is what is testing them now.",en,[],[],[],6,6,37,[],['celg'],https://twitter.com/JohnCendpts/status/1012452458679930880,False,,0,,,,,,,,[],,,,
1012444041647132673,1012444041647132673,2018-06-29 02:44:04 IST,2018-06-29,02:44:04,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$XLRN blood disease drug hits goal in pivotal clinical trial  https://t.co/edwFnfCw2O $CELG is lucky to have a partner that can actually develop drugs without screwing up.,en,[],['https://www.statnews.com/2018/06/28/acceleron-celgene-blood-diseases-clinical-trials/'],[],7,4,29,[],"['xlrn', 'celg']",https://twitter.com/adamfeuerstein/status/1012444041647132673,False,,0,,,,,,,,[],,,,
1012434103516434437,1012434103516434437,2018-06-29 02:04:35 IST,2018-06-29,02:04:35,+0530,102094857,adamfeuerstein,Adam Feuerstein,,I spent a good part of my day writing a preview of the $CELG $XLRN luspatercept trial results for tomorrow morning. Oh well‚Ä¶,en,[],[],[],5,2,13,[],"['celg', 'xlrn']",https://twitter.com/adamfeuerstein/status/1012434103516434437,False,,0,,,,,,,,[],,,,
1011706947811401735,1011706947811401735,2018-06-27 01:55:07 IST,2018-06-27,01:55:07,+0530,15568127,themotleyfool,The Motley Fool,,"In the drug industry, success is measured the same way as it is in Hollywood: How many blockbusters have you produced? For investors, the more relevant question may be, how many blockbusters WILL you produce? $NVS $ABBV $CELG $AZN $AMGN  https://t.co/tMcBRTvpYw",en,[],['https://www.fool.com/investing/2018/06/24/long-term-investors-take-note-these-5-big-pharma-c.aspx'],[],0,5,17,[],"['nvs', 'abbv', 'celg', 'azn', 'amgn']",https://twitter.com/themotleyfool/status/1011706947811401735,False,,0,,,,,,,,[],,,,
1011572337915912193,1011572337915912193,2018-06-26 17:00:14 IST,2018-06-26,17:00:14,+0530,102754598,johncendpts,John Carroll,,Bill Haney believes there‚Äôs a better way to build a biotech ‚Äî and now he has $100M more at Skyhawk to prove it $CELG  https://t.co/Pa3lDpTklx,en,[],['https://endpts.com/bill-haney-believes-theres-a-better-way-to-build-a-biotech-and-now-he-has-100m-more-at-skyhawk-to-prove-it/'],[],1,5,11,[],['celg'],https://twitter.com/JohnCendpts/status/1011572337915912193,False,,0,,,,,,,,[],,,,
1009005916258267136,1009005916258267136,2018-06-19 15:02:11 IST,2018-06-19,15:02:11,+0530,104257356,briansozzi,Brian Sozzi,,Paying careful attention to the GLUM Index today!  https://t.co/oCTYRLxn9M @jimcramer   $CAT $BA $MMM $GE $JNJ $C $GS $LEN $WMT $F $GILD $CELG,en,"[{'screen_name': 'jimcramer', 'name': 'jim cramer', 'id': '14216123'}]",['http://ow.ly/nvLP30kyQEt'],[],0,14,25,[],"['cat', 'ba', 'mmm', 'ge', 'jnj', 'c', 'gs', 'len', 'wmt', 'f', 'gild', 'celg']",https://twitter.com/BrianSozzi/status/1009005916258267136,False,,0,,,,,,,,[],,,,
1007308034794840064,1007308034794840064,2018-06-14 22:35:25 IST,2018-06-14,22:35:25,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Day traders are among the most annoying people on Twitter.   Please, don‚Äôt tell me $CELG problems are solved because the stock is trading higher for four hours.  https://t.co/rIAapu9zNV",en,[],['https://twitter.com/Hrishious/status/1007303942320087043'],[],9,3,53,[],['celg'],https://twitter.com/adamfeuerstein/status/1007308034794840064,False,https://twitter.com/Hrishious/status/1007303942320087043,0,,,,,,,,[],,,,
1007218747420168192,1007218747420168192,2018-06-14 16:40:37 IST,2018-06-14,16:40:37,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$CELG execs.  https://t.co/i5V9BSJ6Lh,fr,[],[],['https://pbs.twimg.com/tweet_video_thumb/DfpcG6iUcAIobpH.jpg'],5,5,54,[],['celg'],https://twitter.com/adamfeuerstein/status/1007218747420168192,False,,1,https://pbs.twimg.com/tweet_video_thumb/DfpcG6iUcAIobpH.jpg,,,,,,,[],,,,
1007034582749806593,1007034582749806593,2018-06-14 04:28:48 IST,2018-06-14,04:28:48,+0530,102754598,johncendpts,John Carroll,,I asked $CELG if they had any response to Faheem Hasnain's response to the company's position on the ozanimod RTF. I got nothing. Their media group follows Death Star rules.  https://t.co/HUkb7RonlJ,en,[],['https://endpts.com/blame-the-ozanimod-fiasco-on-the-receptos-team-just-wait-a-sec-says-ex-ceo-who-sold-the-company-to-celgene-for-7-2b/'],[],3,1,8,[],['celg'],https://twitter.com/JohnCendpts/status/1007034582749806593,False,,0,,,,,,,,[],,,,
1006973725076525056,1006973725076525056,2018-06-14 00:26:59 IST,2018-06-14,00:26:59,+0530,102754598,johncendpts,John Carroll,,"So I talked to Faheem Hasnain about those $CELG remarks -- Blame the ozanimod fiasco on the Receptos team? Just wait a sec, says ex-CEO, who sold the company to Celgene for $7.2B  https://t.co/HUkb7RonlJ",en,[],['https://endpts.com/blame-the-ozanimod-fiasco-on-the-receptos-team-just-wait-a-sec-says-ex-ceo-who-sold-the-company-to-celgene-for-7-2b/'],[],1,4,11,[],['celg'],https://twitter.com/JohnCendpts/status/1006973725076525056,False,,0,,,,,,,,[],,,,
1006883835773059073,1006883835773059073,2018-06-13 18:29:48 IST,2018-06-13,18:29:48,+0530,576436187,carolineylchen,Caroline Chen,,"Pointing fingers at colleagues is never a good luck, IMO. $CELG  https://t.co/XwsiHpVjw8",en,[],['https://twitter.com/bydavidcrow/status/1006871937874788354'],[],1,0,9,[],['celg'],https://twitter.com/CarolineYLChen/status/1006883835773059073,False,https://twitter.com/bydavidcrow/status/1006871937874788354,0,,,,,,,,[],,,,
1006875344329216001,1006875344329216001,2018-06-13 17:56:03 IST,2018-06-13,17:56:03,+0530,102754598,johncendpts,John Carroll,,"$CELG has met the enemy, and they're inside  https://t.co/LUdnKuVmrQ",en,[],['https://endpts.com/top-celgene-exec-pins-the-blame-for-ozanimod-fiasco-on-the-receptos-team-acquired-3-years-ago/'],[],2,1,11,[],['celg'],https://twitter.com/JohnCendpts/status/1006875344329216001,False,,0,,,,,,,,[],,,,
1006871937874788354,1006871937874788354,2018-06-13 17:42:31 IST,2018-06-13,17:42:31,+0530,6810242,bydavidcrow,David Crow,,The real story of how Celgene bungled all-important FDA app for new MS drug - one of biggest biotech shocks of 2018 $CELG  https://t.co/QLW8lPPFqb  https://t.co/1xXjOTW8Y0,en,[],['https://www.ft.com/content/642beb68-6db0-11e8-852d-d8b934ff5ffa'],"['https://pbs.twimg.com/media/Dfkf1-EU8AAgsNM.jpg', 'https://pbs.twimg.com/media/DfkgX8gU8AAlRMk.jpg']",3,10,30,[],['celg'],https://twitter.com/bydavidcrow/status/1006871937874788354,False,,1,https://pbs.twimg.com/media/Dfkf1-EU8AAgsNM.jpg,,,,,,,[],,,,
1006860843143835648,1006860843143835648,2018-06-13 16:58:26 IST,2018-06-13,16:58:26,+0530,102754598,johncendpts,John Carroll,,Top Celgene exec pins the blame for ozanimod fiasco on the Receptos team ‚Äî acquired 3 years ago $CELG h/t @bydavidcrow  https://t.co/LUdnKuVmrQ,en,"[{'screen_name': 'bydavidcrow', 'name': 'david crow', 'id': '6810242'}]",['https://endpts.com/top-celgene-exec-pins-the-blame-for-ozanimod-fiasco-on-the-receptos-team-acquired-3-years-ago/'],[],1,1,6,[],['celg'],https://twitter.com/JohnCendpts/status/1006860843143835648,False,,0,,,,,,,,[],,,,
1006229350977556480,1006229350977556480,2018-06-11 23:09:06 IST,2018-06-11,23:09:06,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Prepping for tomorrow's STAT Plus biotech conference call. We‚Äôll preview some big clinical trial events in 2H. What‚Äôs expected? We‚Äôll discuss. $SRPT, $GBT $CELG $XLRN $SGMO Sign up:  https://t.co/7uLblzzClS",en,[],['https://www.statnews.com/subscribe/plan_D088WleEWGBvsj/?utm_content=bufferba6fd&utm_medium=social&utm_source=twitter&utm_campaign=twitter_organic'],[],3,8,16,[],"['srpt', 'gbt', 'celg', 'xlrn', 'sgmo']",https://twitter.com/adamfeuerstein/status/1006229350977556480,False,,0,,,,,,,,[],,,,
1003613858798424064,1003613858798424064,2018-06-04 17:56:04 IST,2018-06-04,17:56:04,+0530,370238655,jodigralnick,jodi gralnick,,ICYMI: $CELG @Celgene CEO Mark Alles talks EXCLUSIVELY to @megtirrell at #ASCO18 about  personalized immunotherapy treatment for cancer patients and @Celgene investor confidence and pipeline.  https://t.co/Oc91h45ZTg,en,"[{'screen_name': 'celgene', 'name': 'jin', 'id': '1350978062125588490'}, {'screen_name': 'megtirrell', 'name': 'meg tirrell', 'id': '47678782'}, {'screen_name': 'celgene', 'name': 'jin', 'id': '1350978062125588490'}]",['https://cnb.cx/2Jm0T4T'],[],1,6,7,['asco18'],['celg'],https://twitter.com/jodigralnick/status/1003613858798424064,False,,0,,,,,,,,[],,,,
1003573085927362560,1003573085927362560,2018-06-04 15:14:03 IST,2018-06-04,15:14:03,+0530,47678782,megtirrell,Meg Tirrell,,Good morning from #ASCO18! Tune in to @CNBC for our interviews w $CELG $BMY $AZN $LOXO $MRK $BPMC $RHHBY (channel 13 at McCormick Hyatt for those on site). Coverage starts 6amCT/7amET!,en,"[{'screen_name': 'cnbc', 'name': 'cnbc', 'id': '20402945'}]",[],[],1,14,31,['asco18'],"['celg', 'bmy', 'azn', 'loxo', 'mrk', 'bpmc', 'rhhby']",https://twitter.com/megtirrell/status/1003573085927362560,False,,0,,,,,,,,[],,,,
1003435137906946048,1003435137906946048,2018-06-04 06:05:54 IST,2018-06-04,06:05:54,+0530,370238655,jodigralnick,jodi gralnick,,"SET YOUR ALARM: our kick-#ASCO LIVE coverage starts tomorrow on @SquawkCNBC, with $CELG CEO at 710amET and $BMY CEO at 810ET, both EXCLUSIVE with @megtirrell. Then throughout the day $AZN, $LOXO, $BPMC, $MRK, $RHHBY all live and exclusive from #ASCO18. @Celgene @bmsnews",en,"[{'screen_name': 'squawkcnbc', 'name': 'squawk box', 'id': '404422077'}, {'screen_name': 'megtirrell', 'name': 'meg tirrell', 'id': '47678782'}, {'screen_name': 'celgene', 'name': 'jin', 'id': '1350978062125588490'}, {'screen_name': 'bmsnews', 'name': 'bristol myers squibb', 'id': '34010976'}]",[],[],0,1,6,"['asco', 'asco18']","['celg', 'bmy', 'azn', 'loxo', 'bpmc', 'mrk', 'rhhby']",https://twitter.com/jodigralnick/status/1003435137906946048,False,,0,,,,,,,,[],,,,
1003261753982177280,1003261753982177280,2018-06-03 18:36:56 IST,2018-06-03,18:36:56,+0530,370238655,jodigralnick,jodi gralnick,,"TUNE IN TOMORROW: most of the major newsmakers at #ASCO18 are joining @megtirrell LIVE and EXCLUSIVE on @CNBC: $CELG, $BMY, $AZN, $LOXO, $BPMC, $MRK, $RHHBY, starting 710amET on @SquawkCNBC",en,"[{'screen_name': 'megtirrell', 'name': 'meg tirrell', 'id': '47678782'}, {'screen_name': 'cnbc', 'name': 'cnbc', 'id': '20402945'}, {'screen_name': 'squawkcnbc', 'name': 'squawk box', 'id': '404422077'}]",[],[],1,8,9,['asco18'],"['celg', 'bmy', 'azn', 'loxo', 'bpmc', 'mrk', 'rhhby']",https://twitter.com/jodigralnick/status/1003261753982177280,False,,0,,,,,,,,[],,,,
1002893667164737537,1002893667164737537,2018-06-02 18:14:17 IST,2018-06-02,18:14:17,+0530,102754598,johncendpts,John Carroll,,"ICYMI: Bluebird, Celgene add a promising chapter to their success story with BCMA-targeting CAR-T ‚Äî but fall short for investors $BLUE $CELG  https://t.co/hbw5BgkXbm",en,[],['https://endpts.com/bluebird-celgene-add-another-promising-chapter-to-their-success-story-with-bcma-targeting-car-t-bb2121/'],[],0,2,8,[],"['blue', 'celg']",https://twitter.com/JohnCendpts/status/1002893667164737537,False,,0,,,,,,,,[],,,,
1002712330961145857,1002707928044920832,2018-06-02 06:13:43 IST,2018-06-02,06:13:43,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"@AndyBiotech I had to twist arms and ask multiple times to get info on relapses/deaths from $BLUE. A bit disappointed. I suspect this is $CELG negative, obstructionist influence at work.",en,[],[],[],3,3,18,[],"['blue', 'celg']",https://twitter.com/adamfeuerstein/status/1002712330961145857,False,,0,,,,,,,,"[{'screen_name': 'AndyBiotech', 'name': 'Andy Biotech', 'id': '632341632'}]",,,,
1002674602290663424,1002674602290663424,2018-06-02 03:43:48 IST,2018-06-02,03:43:48,+0530,44438256,matthewherper,Matthew Herper,,"Bluebird Bio's ""Impressive"" Killer Cells Battle Myeloma, But Are Not A Cure $BLUE $CELG $GSK  https://t.co/JYzVJIWXNc",en,[],['https://www.forbes.com/sites/matthewherper/2018/06/01/bluebird-bios-impressive-killer-cells-battle-myeloma-but-are-not-a-cure/#7df97dfb5269'],[],3,12,24,[],"['blue', 'celg', 'gsk']",https://twitter.com/matthewherper/status/1002674602290663424,False,,0,,,,,,,,[],,,,
1002670789567696897,1002670789567696897,2018-06-02 03:28:39 IST,2018-06-02,03:28:39,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$BLUE $CELG CAR-T delays multiple myeloma progression by one year, but is that enough?  https://t.co/XlLHiqtEMO #ASCO18",en,[],['https://www.statnews.com/2018/06/01/bluebird-bio-car-t/'],[],11,33,51,['asco18'],"['blue', 'celg']",https://twitter.com/adamfeuerstein/status/1002670789567696897,False,,0,,,,,,,,[],,,,
1002670448805543941,1002670448805543941,2018-06-02 03:27:18 IST,2018-06-02,03:27:18,+0530,102754598,johncendpts,John Carroll,,"Bluebird, Celgene add another promising chapter to their success story with BCMA-targeting CAR-T bb2121 #ASCO18 $CELG $BLUE  https://t.co/hbw5BgkXbm",en,[],['https://endpts.com/bluebird-celgene-add-another-promising-chapter-to-their-success-story-with-bcma-targeting-car-t-bb2121/'],[],3,28,34,['asco18'],"['celg', 'blue']",https://twitter.com/JohnCendpts/status/1002670448805543941,False,,0,,,,,,,,[],,,,
1002662583348932608,1002662583348932608,2018-06-02 02:56:03 IST,2018-06-02,02:56:03,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$BLUE $CELG BB2121 (BCMA CAR-T) update coming at top of the hour. Friday night news... ü§∑üèª‚Äç‚ôÇÔ∏è,en,[],[],[],1,4,26,[],"['blue', 'celg']",https://twitter.com/adamfeuerstein/status/1002662583348932608,False,,0,,,,,,,,[],,,,
1002555875863793664,1002555875863793664,2018-06-01 19:52:02 IST,2018-06-01,19:52:02,+0530,274233761,bradloncar,Brad Loncar,,Great slide from Oppenheimer illustrates how all the action in our sector over the last year has been from mid and small cap companies. Large caps like $CELG $GILD etc not so much.  https://t.co/SbBXdrmEoz,en,[],[],['https://pbs.twimg.com/media/DenLP6AU8AAplg-.jpg'],3,5,18,[],"['celg', 'gild']",https://twitter.com/bradloncar/status/1002555875863793664,False,,1,https://pbs.twimg.com/media/DenLP6AU8AAplg-.jpg,,,,,,,[],,,,
1001464050566430720,1001464050566430720,2018-05-29 19:33:30 IST,2018-05-29,19:33:30,+0530,102094857,adamfeuerstein,Adam Feuerstein,,#ASCO18 starts on Friday night with $BLUE $CELG BCMA CAR-T data. STAT‚Äôs @sxbegle will be covering ASCO from Chicago while I write from Boston. We‚Äôll have stories + a free daily ASCO email newsletter. Register for that here:  https://t.co/ooxAVz0vfM,en,"[{'screen_name': 'sxbegle', 'name': 'sharon begley', 'id': '346605991'}]",['https://signup.statnews.com/asco-30-seconds'],[],0,6,17,['asco18'],"['blue', 'celg']",https://twitter.com/adamfeuerstein/status/1001464050566430720,False,,0,,,,,,,,[],,,,
1000026257805991942,1000026257805991942,2018-05-25 20:20:14 IST,2018-05-25,20:20:14,+0530,57124794,annaedney,Anna Edney,,Tax reform means pharma will spend more on research &amp; devel.....oh  https://t.co/X9SKIvTPnX $PFE $AMGN $CELG $ABBV via @BTLipschultz,en,"[{'screen_name': 'btlipschultz', 'name': 'bailey lipschultz', 'id': '1705420616'}]",['https://www.bloomberg.com/news/articles/2018-05-25/biopharma-deploying-trump-windfall-to-buy-back-billions-in-stock'],[],1,18,13,[],"['pfe', 'amgn', 'celg', 'abbv']",https://twitter.com/annaedney/status/1000026257805991942,False,,0,,,,,,,,[],,,,
999989742522585088,999989742522585088,2018-05-25 17:55:08 IST,2018-05-25,17:55:08,+0530,15568127,themotleyfool,The Motley Fool,,"Fact: A steady drumbeat of negative news has sucked the air out of Celgene stock. Postulate: Mr. Market is so focused on what‚Äôs recent, he‚Äôs ignoring the solid fundamentals. $CELG.  https://t.co/jMlVGZxO85",en,[],['https://www.fool.com/investing/2018/05/24/i-just-bought-my-first-new-stock-in-8-months-and-t.aspx'],[],0,3,20,[],['celg'],https://twitter.com/themotleyfool/status/999989742522585088,False,,0,,,,,,,,[],,,,
999277425174503424,999277425174503424,2018-05-23 18:44:38 IST,2018-05-23,18:44:38,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$CELG would have raised the $ARMO offer to $75 after KN-189  https://t.co/aGei8mSx1g,en,[],['https://twitter.com/andybiotech/status/999275823076175872'],[],3,2,21,[],"['celg', 'armo']",https://twitter.com/adamfeuerstein/status/999277425174503424,False,https://twitter.com/andybiotech/status/999275823076175872,0,,,,,,,,[],,,,
998900298457518080,998900298457518080,2018-05-22 17:46:04 IST,2018-05-22,17:46:04,+0530,873399943,jacobplieth,Jacob Plieth,,$CELG CAR-T data at #EHA18: LT efficacy of JCAR017 in pivotal Transcend trial; bb2121 anti-BCMA $BLUE update,en,[],[],[],0,3,11,['eha18'],"['celg', 'blue']",https://twitter.com/JacobPlieth/status/998900298457518080,False,,0,,,,,,,,[],,,,
998681574194413569,998681574194413569,2018-05-22 03:16:56 IST,2018-05-22,03:16:56,+0530,102754598,johncendpts,John Carroll,,"I wonder, the next time $CELG sees a few billion go pffft on a story, do you think the media team will be roused to actually send a response to a query? Times have changed, folks. You're not that $CELG any more.",en,[],[],[],4,0,30,[],"['celg', 'celg']",https://twitter.com/JohnCendpts/status/998681574194413569,False,,0,,,,,,,,[],,,,
998666779806392321,998666779806392321,2018-05-22 02:18:09 IST,2018-05-22,02:18:09,+0530,102754598,johncendpts,John Carroll,,"So $CELG's stock went down 5% today after my Golumbeski story -- hey, guys, he seems to have really retired to do other things. Interesting timing, but chill out.  https://t.co/ihUkiSqXfE",en,[],['https://endpts.com/bd-chief-george-golumbeski-is-the-latest-top-exec-to-exit-celgene-during-management-overhaul/'],[],0,0,5,[],['celg'],https://twitter.com/JohnCendpts/status/998666779806392321,False,,0,,,,,,,,[],,,,
998656989751373824,998656989751373824,2018-05-22 01:39:15 IST,2018-05-22,01:39:15,+0530,102754598,johncendpts,John Carroll,,"Wrestling with setbacks, Celgene adds $65M discovery alliance with Evotec to beef up on new cancer drugs $CELG  https://t.co/fMnCd9GmFA",en,[],['https://endpts.com/wrestling-with-setbacks-celgene-adds-65m-discovery-alliance-with-evotec-to-beef-up-on-new-cancer-drugs/'],[],1,7,10,[],['celg'],https://twitter.com/JohnCendpts/status/998656989751373824,False,,0,,,,,,,,[],,,,
998570987464601602,998570987464601602,2018-05-21 19:57:30 IST,2018-05-21,19:57:30,+0530,102754598,johncendpts,John Carroll,,"I talked to George Golumbeski about his departure from Celgene, and his new plans for biotech $CELG  https://t.co/ihUkiSqXfE",en,[],['https://endpts.com/bd-chief-george-golumbeski-is-the-latest-top-exec-to-exit-celgene-during-management-overhaul/'],[],0,6,7,[],['celg'],https://twitter.com/JohnCendpts/status/998570987464601602,False,,0,,,,,,,,[],,,,
998561030706954240,998561030706954240,2018-05-21 19:17:56 IST,2018-05-21,19:17:56,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$CELG BD chief George Golumbeski is the latest top exec to exit during management overhaul -  https://t.co/idZAcRONTO via @endpts,en,"[{'screen_name': 'endpts', 'name': 'endpoints news', 'id': '3460109487'}]",['https://endpts.com/bd-chief-george-golumbeski-is-the-latest-top-exec-to-exit-celgene-during-management-overhaul/'],[],2,8,15,[],['celg'],https://twitter.com/adamfeuerstein/status/998561030706954240,False,,0,,,,,,,,[],,,,
997152028496363521,997152028496363521,2018-05-17 21:59:04 IST,2018-05-17,21:59:04,+0530,47678782,megtirrell,Meg Tirrell,,"FDA publishes list of drugs for which it‚Äôs received inquiries from generic manufacturers indicating they can‚Äôt get access. Among highest #s: $CELG 31 (8 Pomalyst, 13 Revlimid, 10 Thalomid) $ATLN 22 (8 Opsumit, 14 Tracleer) $GILD 11 (10 Letairis, 1 Truvada)  https://t.co/SHlFUYK4Yn",en,[],['https://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ucm607738.htm'],[],4,14,11,['s'],"['celg', 'atln', 'gild']",https://twitter.com/megtirrell/status/997152028496363521,False,,0,,,,,,,,[],,,,
997131971699597313,997131971699597313,2018-05-17 20:39:22 IST,2018-05-17,20:39:22,+0530,42703163,sarahkarlin,Sarah Karlin-Smith,,"It‚Äôs not just Celegene. Pfizer, Novartis, GSK, Bayer, Teva, Mylan and more. $celg $pfe $nvs $gsk $teva $myl  https://t.co/YEI7NlMRt3",en,[],['https://twitter.com/swheaton/status/997130004839452672'],[],3,1,7,[],"['celg', 'pfe', 'nvs', 'gsk', 'teva', 'myl']",https://twitter.com/SarahKarlin/status/997131971699597313,False,https://twitter.com/swheaton/status/997130004839452672,0,,,,,,,,[],,,,
997106407446007808,997105664110493696,2018-05-17 18:57:47 IST,2018-05-17,18:57:47,+0530,57124794,annaedney,Anna Edney,,"Companies that top the naughty list: Celgene, Gilead, Novartis  $CELG $GILD $NOVN",en,[],[],[],2,5,13,[],"['celg', 'gild', 'novn']",https://twitter.com/annaedney/status/997106407446007808,False,,0,,,,,,,,[],,,,
997098631693062145,997094488995753984,2018-05-17 18:26:53 IST,2018-05-17,18:26:53,+0530,274233761,bradloncar,Brad Loncar,,"Another thing I‚Äôll say about this is I‚Äôve seen $CELG BD head talk about this Jounce deal at a conference and how to them this was special and they threw so much money at because it is ‚Äútargeted, biomarker driven etc‚Äù development. You have to wonder if Celgene has any clue.",en,[],[],[],9,7,45,[],['celg'],https://twitter.com/bradloncar/status/997098631693062145,False,,0,,,,,,,,[],,,,
996087300772810755,996087300772810755,2018-05-14 23:28:13 IST,2018-05-14,23:28:13,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"FDA to name companies accused of hindering generic drug development  https://t.co/tPNu53lLHp via @ikeswetlitz Hello, $CELG!",en,"[{'screen_name': 'ikeswetlitz', 'name': 'ike swetlitz', 'id': '1278691560'}]",['https://www.statnews.com/2018/05/14/fda-generic-drugs-withholding-samples/'],[],2,14,25,[],['celg'],https://twitter.com/adamfeuerstein/status/996087300772810755,False,,0,,,,,,,,[],,,,
994717833497104384,994717202812153856,2018-05-11 04:46:27 IST,2018-05-11,04:46:27,+0530,274233761,bradloncar,Brad Loncar,,Other recent names include:  Dodgers Merger Sub = $GILD + $KITE Blue Magpie Corp = $CELG + $JUNO,en,[],[],[],2,0,6,[],"['gild', 'kite', 'celg', 'juno']",https://twitter.com/bradloncar/status/994717833497104384,False,,0,,,,,,,,[],,,,
994642032273559552,994642032273559552,2018-05-10 23:45:14 IST,2018-05-10,23:45:14,+0530,15568127,themotleyfool,The Motley Fool,,"Have you *ever* had a 100-bagger in your portfolio? It took them a couple decades, but $BIIB $CELG and $GILD all pulled off that massive growth feat.  https://t.co/LJyldaRPUI",en,[],['https://www.fool.com/investing/2018/05/09/3-stocks-that-turned-10000-into-1-million.aspx'],[],1,5,24,[],"['biib', 'celg', 'gild']",https://twitter.com/themotleyfool/status/994642032273559552,False,,0,,,,,,,,[],,,,
993440208803844096,993440208803844096,2018-05-07 16:09:37 IST,2018-05-07,16:09:37,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Leerink‚Äôs Geoff Porges says $CELG still sucks, but stock also undervalued.   Sell-side notes are often confusing.",en,[],[],[],3,0,20,[],['celg'],https://twitter.com/adamfeuerstein/status/993440208803844096,False,,0,,,,,,,,[],,,,
992406781547700224,992406781547700224,2018-05-04 19:43:09 IST,2018-05-04,19:43:09,+0530,102094857,adamfeuerstein,Adam Feuerstein,,A strong $CELG earnings report gives investors reasons to start trusting again  https://t.co/c6USMNPFb9 Start...,en,[],['https://www.statnews.com/2018/05/04/celgene-earnings-report-investors-trust/'],[],3,1,8,[],['celg'],https://twitter.com/adamfeuerstein/status/992406781547700224,False,,0,,,,,,,,[],,,,
992405767142637569,992405767142637569,2018-05-04 19:39:07 IST,2018-05-04,19:39:07,+0530,21328656,ibdinvestors,Investors.com,,"Friday's big headlines: Warren Buffett's Berkshire Hathaway bought 75 million shares of Apple in one quarter, Alibaba says revenue growth should hit 60%, Nike's CEO says ""sorry,"" and more. Read all about it:  https://t.co/hSMHLJmXoJ $BABA $NKE $AAPL $BRKB $CELG $VFC #warrenbuffett  https://t.co/LssVZdPIpZ",en,[],['http://ow.ly/Wb5M30gZSlO'],[],0,6,6,['warrenbuffett'],"['baba', 'nke', 'aapl', 'brkb', 'celg', 'vfc']",https://twitter.com/IBDinvestors/status/992405767142637569,False,,1,https://pbs.twimg.com/ext_tw_video_thumb/992405682816106498/pu/img/M6SRhcIxWnvT9Prz.jpg,,,,,,,[],,,,
992398295531126784,992398295531126784,2018-05-04 19:09:26 IST,2018-05-04,19:09:26,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$CELG CEO Mark Alles needs to work on controlling his temper.,en,[],[],[],3,1,15,[],['celg'],https://twitter.com/adamfeuerstein/status/992398295531126784,False,,0,,,,,,,,[],,,,
992397945713676288,992397945713676288,2018-05-04 19:08:02 IST,2018-05-04,19:08:02,+0530,47678782,megtirrell,Meg Tirrell,,The word of the day on the $CELG call is: METABOLITE,en,[],[],[],1,4,26,[],['celg'],https://twitter.com/megtirrell/status/992397945713676288,False,,0,,,,,,,,[],,,,
992388603857731584,992388603857731584,2018-05-04 18:30:55 IST,2018-05-04,18:30:55,+0530,873399943,jacobplieth,Jacob Plieth,,No fewer than three anti-BCMA CARs in $CELG's multiple myeloma armamentarium $BLUE  https://t.co/WXI0YSwtry,en,[],[],['https://pbs.twimg.com/media/DcWsKWeWkAAi2HL.jpg'],2,2,16,[],"['celg', 'blue']",https://twitter.com/JacobPlieth/status/992388603857731584,False,,1,https://pbs.twimg.com/media/DcWsKWeWkAAi2HL.jpg,,,,,,,[],,,,
992387932702019593,992387932702019593,2018-05-04 18:28:15 IST,2018-05-04,18:28:15,+0530,873399943,jacobplieth,Jacob Plieth,,$CELG #ASCO18  https://t.co/NcSxglg3eL,in,[],[],['https://pbs.twimg.com/media/DcWrjdrW0AAe8-e.jpg'],0,1,9,['asco18'],['celg'],https://twitter.com/JacobPlieth/status/992387932702019593,False,,1,https://pbs.twimg.com/media/DcWrjdrW0AAe8-e.jpg,,,,,,,[],,,,
992376424936984576,992376424936984576,2018-05-04 17:42:31 IST,2018-05-04,17:42:31,+0530,47348249,michael_gilman,Michael Gilman,,"Interesting tidbit gleaned from $CELG slides: Almost 30% of annual EPS growth attributable to share buybacks. Strong operating gains as well, so good for them. But this is why companies buy back shares. It's completely rational in an earnings-driven universe.",en,[],[],[],5,7,24,[],['celg'],https://twitter.com/michael_gilman/status/992376424936984576,False,,0,,,,,,,,[],,,,
992367688583405568,992367688583405568,2018-05-04 17:07:48 IST,2018-05-04,17:07:48,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$CELG Q1 EPS looks good. No blowups! Top/bottom line beats. Ozanimod refile in 1H ‚Äô19 is ok, not the disaster people feared. Updated ‚Äô18 guidance good. Exhale.",en,[],[],[],8,10,41,[],['celg'],https://twitter.com/adamfeuerstein/status/992367688583405568,False,,0,,,,,,,,[],,,,
991689854118498305,991689854118498305,2018-05-02 20:14:20 IST,2018-05-02,20:14:20,+0530,873399943,jacobplieth,Jacob Plieth,,Why does Kymriah's DLBCL label exclude 58% of patients enrolled into Juliet? Via @EPVantage  https://t.co/7mbLW7xSeh $NVS $GILD $CELG,en,"[{'screen_name': 'epvantage', 'name': 'vantage', 'id': '841963175729856512'}]",['http://epvantage.com/Universal/View.aspx?type=Story&id=784649&isEPVantage=yes'],[],3,12,22,[],"['nvs', 'gild', 'celg']",https://twitter.com/JacobPlieth/status/991689854118498305,False,,0,,,,,,,,[],,,,
991592080270032896,991592080270032896,2018-05-02 13:45:49 IST,2018-05-02,13:45:49,+0530,873399943,jacobplieth,Jacob Plieth,,If you're trying to figure out the numbers on Kymriah's US DLBCL label this was the state of play at #ASH17  https://t.co/QUOx8OwGz5 $NVS $GILD $CELG  https://t.co/9s1SXoEVKx,en,[],['http://bit.ly/2Kt3Ga9'],['https://pbs.twimg.com/media/DcLXoq7X0AEKjYh.jpg'],0,6,18,['ash17'],"['nvs', 'gild', 'celg']",https://twitter.com/JacobPlieth/status/991592080270032896,False,,1,https://pbs.twimg.com/media/DcLXoq7X0AEKjYh.jpg,,,,,,,[],,,,
991005408847425536,991005408847425536,2018-04-30 22:54:36 IST,2018-04-30,22:54:36,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"I don‚Äôt know how long $CELG ozanimod delay will last, but FDA making the co. do 3 yrs of preclinical work just to refile really goes against everything @SGottliebFDA has been doing at the agency to accelerate drug development/approvals.",en,[],[],[],3,2,26,[],['celg'],https://twitter.com/adamfeuerstein/status/991005408847425536,False,,0,,,,,,,,[],,,,
990975562503028736,990975562503028736,2018-04-30 20:56:00 IST,2018-04-30,20:56:00,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$CELG -6%. Morgan Stanley‚Äôs Matt Harrison predicting 1-3 year filling delay for ozanimod, based on his analysis of available data and precedent.",en,[],[],[],3,8,21,[],['celg'],https://twitter.com/adamfeuerstein/status/990975562503028736,False,,0,,,,,,,,[],,,,
990942133384286208,990942133384286208,2018-04-30 18:43:10 IST,2018-04-30,18:43:10,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$CELG beaten-down stock is cheap, but only if investors regain trust in its financial outlook  https://t.co/qtLEKB8Xyq earnings Friday.",en,[],['https://www.statnews.com/2018/04/30/celgene-beaten-down-stock/'],[],4,6,17,[],['celg'],https://twitter.com/adamfeuerstein/status/990942133384286208,False,,0,,,,,,,,[],,,,
990713367433240576,990713367433240576,2018-04-30 03:34:08 IST,2018-04-30,03:34:08,+0530,14886375,stocktwits,Stocktwits,,Here‚Äôs who reports earnings this week:  Mon - $MCD $AKS $RIG $AGN $AKAM $FDC Tue - $AAPL $SNAP $GILD $SHOP $PFE $BP $MRK $UA Wed - $TSLA $FEYE $SQ $DDD $FIT $CHK $CVS $MRO $SSYS Thu - $GPRO $ATVI $CARA $TEVA $P $AA $SRPT $OSTK Fri - $AMD $BABA $CELG   https://t.co/uSdZZVvSRQ,en,[],['https://stocktwits.com/discover/earnings-calendar/2018-04-30'],[],8,51,121,[],"['mcd', 'aks', 'rig', 'agn', 'akam', 'fdc', 'aapl', 'snap', 'gild', 'shop', 'pfe', 'bp', 'mrk', 'ua', 'tsla', 'feye', 'sq', 'ddd', 'fit', 'chk', 'cvs', 'mro', 'ssys', 'gpro', 'atvi', 'cara', 'teva', 'p', 'aa', 'srpt', 'ostk', 'amd', 'baba', 'celg']",https://twitter.com/Stocktwits/status/990713367433240576,False,,0,,,,,,,,[],,,,
990655202318577664,990655202318577664,2018-04-29 23:43:00 IST,2018-04-29,23:43:00,+0530,274233761,bradloncar,Brad Loncar,,Huge week of earnings coming up.  M: $AGN $NBIX T: $GILD $INCY $IRWD $MRK W: $EXEL $NVO $UTHR T: $ALNY $REGN $SAGE $SRPT F: $AGIO $CELG $IONS  The full list:  https://t.co/iMjW2l3E9A  https://t.co/fa6YYIzhOy,en,[],['http://www.loncarblog.com/april-30-earnings'],['https://pbs.twimg.com/media/Db6nPQMVQAAstIF.jpg'],1,20,42,[],"['agn', 'nbix', 'gild', 'incy', 'irwd', 'mrk', 'exel', 'nvo', 'uthr', 'alny', 'regn', 'sage', 'srpt', 'agio', 'celg', 'ions']",https://twitter.com/bradloncar/status/990655202318577664,False,,1,https://pbs.twimg.com/media/Db6nPQMVQAAstIF.jpg,,,,,,,[],,,,
989489097239605250,989489097239605250,2018-04-26 18:29:19 IST,2018-04-26,18:29:19,+0530,102754598,johncendpts,John Carroll,,Celgene‚Äôs disclosures about ozanimod this week spur analysts‚Äô fears of a lengthy delay for a key drug $CELG (down 18% from January 1)  https://t.co/jxTVaexq7s,en,[],['https://endpts.com/celgenes-disclosures-about-ozanimod-this-week-spur-analysts-fears-of-a-lengthy-delay-for-a-key-drug/'],[],0,4,8,[],['celg'],https://twitter.com/JohnCendpts/status/989489097239605250,False,,0,,,,,,,,[],,,,
988820306562289665,988820306562289665,2018-04-24 22:11:47 IST,2018-04-24,22:11:47,+0530,873399943,jacobplieth,Jacob Plieth,,$NVS just confirmed to me that it filed Kymriah in Japan for both ped ALL and DLBCL $GILD $CELG cc @BLLPHD @cells_nnm,en,"[{'screen_name': 'bllphd', 'name': 'bruce levine, ph.d.', 'id': '211353183'}, {'screen_name': 'cells_nnm', 'name': 'alexey bersenev', 'id': '14063950'}]",[],[],0,9,10,[],"['nvs', 'gild', 'celg']",https://twitter.com/JacobPlieth/status/988820306562289665,False,,0,,,,,,,,[],,,,
988388356869455872,988388356869455872,2018-04-23 17:35:22 IST,2018-04-23,17:35:22,+0530,873399943,jacobplieth,Jacob Plieth,,So $CELG comes out of the $PRTA mess looking like even bigger fools than Woodford &amp; Co?,en,[],[],[],2,2,9,[],"['celg', 'prta']",https://twitter.com/JacobPlieth/status/988388356869455872,False,,0,,,,,,,,[],,,,
984067542229704707,984067542229704707,2018-04-11 19:25:59 IST,2018-04-11,19:25:59,+0530,6810242,bydavidcrow,David Crow,,"Wealthy Chinese often travel to US for healthcare, but rare to hear of someone going other way: Craig Chase's remarkable story of how his myeloma was cured by a 'Made in China' cell therapy  https://t.co/ZwGgfCcNHi $JNJ $CELG $BLUE $CLLS $NVS $GILD  https://t.co/CKHSeIcdm2",en,[],['https://www.ft.com/content/30b5a944-3b57-11e8-b9f9-de94fa33a81e'],['https://pbs.twimg.com/media/DagcIDfW0AEyGM7.jpg'],5,41,85,[],"['jnj', 'celg', 'blue', 'clls', 'nvs', 'gild']",https://twitter.com/bydavidcrow/status/984067542229704707,False,,1,https://pbs.twimg.com/media/DagcIDfW0AEyGM7.jpg,,,,,,,[],,,,
984049565547589633,984049565547589633,2018-04-11 18:14:33 IST,2018-04-11,18:14:33,+0530,6810242,bydavidcrow,David Crow,,Novartis CEO @VasNarasimhan explains why his company could turn to China to help manufacture its Car-T treatments: our Big Read on why the Chinese cell therapy revolution is real. $NVS $GILD $CELG  https://t.co/ZwGgfCcNHi  https://t.co/dqSLejaDor,en,"[{'screen_name': 'vasnarasimhan', 'name': 'vas narasimhan', 'id': '723488741348782080'}]",['https://www.ft.com/content/30b5a944-3b57-11e8-b9f9-de94fa33a81e'],['https://pbs.twimg.com/media/DagLz8rUMAAPA7e.jpg'],0,10,12,[],"['nvs', 'gild', 'celg']",https://twitter.com/bydavidcrow/status/984049565547589633,False,,1,https://pbs.twimg.com/media/DagLz8rUMAAPA7e.jpg,,,,,,,[],,,,
983384185288130560,983384185288130560,2018-04-09 22:10:34 IST,2018-04-09,22:10:34,+0530,274233761,bradloncar,Brad Loncar,,Sol Barer was asked about $CELG‚Äôs current business model of external innovation via partnerships. Said he can‚Äôt comment on Celgene specifically but in general believes R&amp;D is central to the business. Says you need to spend time doing work and understanding things well internally.  https://t.co/MIEAV0JVd0,en,[],[],['https://pbs.twimg.com/media/DaWutF1WsAAYLrr.jpg'],2,4,12,[],[],https://twitter.com/bradloncar/status/983384185288130560,False,,1,https://pbs.twimg.com/media/DaWutF1WsAAYLrr.jpg,,,,,,,[],,,,
983020349444050945,983020349444050945,2018-04-08 22:04:49 IST,2018-04-08,22:04:49,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Not much new here. I think the deal investors prefer to see is $CELG selling itself in a large biopharma merger/consolidation, not $CELG buying another one of its smaller partners.  https://t.co/h8jrDBav68",en,[],['https://twitter.com/bydavidcrow/status/983006889574354945'],[],6,7,31,[],"['celg', 'celg']",https://twitter.com/adamfeuerstein/status/983020349444050945,False,https://twitter.com/bydavidcrow/status/983006889574354945,0,,,,,,,,[],,,,
983006889574354945,983006889574354945,2018-04-08 21:11:20 IST,2018-04-08,21:11:20,+0530,6810242,bydavidcrow,David Crow,,"Celgene hunting for deals to offset loss of Revlimid patents, weighing offers for Agios and Jounce, per advisers (with @JFK_America) $CELG $AGIO $JNCE  https://t.co/qB40XBzrBO",en,"[{'screen_name': 'jfk_america', 'name': 'james fontanella-khan', 'id': '110929302'}]",['https://www.ft.com/content/192c3774-390f-11e8-8b98-2f31af407cc8?desktop=true&segmentId=d8d3e364-5197-20eb-17cf-2437841d178a#myft:notification:instant-email:content'],[],3,28,24,[],"['celg', 'agio', 'jnce']",https://twitter.com/bydavidcrow/status/983006889574354945,False,,0,,,,,,,,[],,,,
981929095679430656,981929095679430656,2018-04-05 21:48:34 IST,2018-04-05,21:48:34,+0530,873399943,jacobplieth,Jacob Plieth,,Boehringer gives CD47 approach a new lease of life. Via @EPVantage  https://t.co/RlgD8ZwWsf $TRIL $OSE.PA $CELG  https://t.co/ICrBqYBNwx,en,"[{'screen_name': 'epvantage', 'name': 'vantage', 'id': '841963175729856512'}]",['http://www.epvantage.com/Universal/View.aspx?type=Story&id=778097&isEPVantage=yes'],['https://pbs.twimg.com/media/DaCDTRzWAAAVQt7.jpg'],3,13,17,[],"['tril', 'ose.pa', 'celg']",https://twitter.com/JacobPlieth/status/981929095679430656,False,,1,https://pbs.twimg.com/media/DaCDTRzWAAAVQt7.jpg,,,,,,,[],,,,
981561323258548224,981561323258548224,2018-04-04 21:27:10 IST,2018-04-04,21:27:10,+0530,6810242,bydavidcrow,David Crow,,The biotech M&amp;A class of 2015-16: Where are they now. @JFK_America and I take a look at the deals done during the last frenzy and ask how they're faring (hint: not so well). $ABBV $CELG $ALXN $PFE  https://t.co/KwBzP7weWE,en,"[{'screen_name': 'jfk_america', 'name': 'james fontanella-khan', 'id': '110929302'}]",['https://www.ft.com/content/1393a7f6-339d-11e8-ac48-10c6fdc22f03'],[],1,8,14,[],"['abbv', 'celg', 'alxn', 'pfe']",https://twitter.com/bydavidcrow/status/981561323258548224,False,,0,,,,,,,,[],,,,
981182247146524674,981182247146524674,2018-04-03 20:20:51 IST,2018-04-03,20:20:51,+0530,873399943,jacobplieth,Jacob Plieth,,"$PFE says goodbye (but not quite farewell) to $CLLS. My take on Allogene and CAR-T's A-team, via @EPVantage  https://t.co/YngoUK62No $GILD $CELG $NVS",en,"[{'screen_name': 'epvantage', 'name': 'vantage', 'id': '841963175729856512'}]",['http://www.epvantage.com/Universal/View.aspx?type=Story&id=777431&isEPVantage=yes'],[],7,25,32,[],"['pfe', 'clls', 'gild', 'celg', 'nvs']",https://twitter.com/JacobPlieth/status/981182247146524674,False,,0,,,,,,,,[],,,,
981147392010579968,981139851247529989,2018-04-03 18:02:21 IST,2018-04-03,18:02:21,+0530,873399943,jacobplieth,Jacob Plieth,,"Allogene among biggest seed/series A rounds. $JUNO 's was $120m, $ADAP $104m, Tmunity $100m. $KITE $GILD $CELG $CLLS  https://t.co/jgfnphFoCV",en,[],[],['https://pbs.twimg.com/media/DZ28PZIXcAAA5k1.jpg'],1,7,10,[],"['juno', 'adap', 'kite', 'gild', 'celg', 'clls']",https://twitter.com/JacobPlieth/status/981147392010579968,False,,1,https://pbs.twimg.com/media/DZ28PZIXcAAA5k1.jpg,,,,,,,[],,,,
980918307695071233,980918307695071233,2018-04-03 02:52:03 IST,2018-04-03,02:52:03,+0530,102754598,johncendpts,John Carroll,,"Command and control: In sudden revamp, Celgene CEO Alles bids his COO goodbye and looks to regain confidence with management shuffle $CELG  https://t.co/ezZUTuNwRx",en,[],['https://endpts.com/in-sudden-revamp-celgene-ceo-alles-bids-his-coo-goodbye-and-looks-to-regain-confidence-with-management-shuffle/'],[],0,2,7,[],['celg'],https://twitter.com/JohnCendpts/status/980918307695071233,False,,0,,,,,,,,[],,,,
980907714279813120,980907714279813120,2018-04-03 02:09:58 IST,2018-04-03,02:09:58,+0530,3043828834,cgrantwsj,Charley Grant,,$CELG announces COO is out effective immediately. Our piece on the self-inflicted mess there from last month.  https://t.co/NmhX0fusPH,en,[],['https://www.wsj.com/articles/can-celgene-save-itself-1519900201'],[],1,2,8,[],['celg'],https://twitter.com/CGrantWSJ/status/980907714279813120,False,,0,,,,,,,,[],,,,
980907344832946176,980907344832946176,2018-04-03 02:08:30 IST,2018-04-03,02:08:30,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Keep rocking, Mark. $CELG  https://t.co/tVcwrROFT9",en,[],[],['https://pbs.twimg.com/tweet_video_thumb/DZziBu_XkAA1DBF.jpg'],1,2,9,[],['celg'],https://twitter.com/adamfeuerstein/status/980907344832946176,False,,1,https://pbs.twimg.com/tweet_video_thumb/DZziBu_XkAA1DBF.jpg,,,,,,,[],,,,
980906080808120320,980906080808120320,2018-04-03 02:03:28 IST,2018-04-03,02:03:28,+0530,274233761,bradloncar,Brad Loncar,,Is there a job at $CELG that Mark Alles won't be doing?,en,[],[],[],5,2,17,[],['celg'],https://twitter.com/bradloncar/status/980906080808120320,False,,0,,,,,,,,[],,,,
980856154950598658,980856154950598658,2018-04-02 22:45:05 IST,2018-04-02,22:45:05,+0530,44438256,matthewherper,Matthew Herper,,A reminder re: $ALKS: RTF letters typically mean very long delays. See my earlier story on $CELG.  https://t.co/Q7KKlh5zbS,en,[],['https://www.forbes.com/sites/matthewherper/2018/02/28/how-bad-is-celgenes-fda-foul-up-two-decades-of-biotech-says-it-cant-be-good/#2cba3bf3ebd3'],[],2,3,9,[],"['alks', 'celg']",https://twitter.com/matthewherper/status/980856154950598658,False,,0,,,,,,,,[],,,,
978259104216047616,978259104216047616,2018-03-26 18:45:20 IST,2018-03-26,18:45:20,+0530,15568127,themotleyfool,The Motley Fool,,"Buy when the market is selling. But ‚ÄúBuy WHAT?"" is the question. @TMFUltraLong is fixin‚Äô to use his ‚Äúdry powder‚Äù on $FB $CELG $ARLP and $WHR  https://t.co/7vTVGch9fL",en,"[{'screen_name': 'tmfultralong', 'name': 'sean williams', 'id': '389319582'}]",['https://www.fool.com/investing/2018/03/23/4-top-stocks-on-my-buy-radar-during-this-correctio.aspx'],[],1,7,18,[],"['fb', 'celg', 'arlp', 'whr']",https://twitter.com/themotleyfool/status/978259104216047616,False,,0,,,,,,,,[],,,,
977197746112299008,902928283771297792,2018-03-23 20:27:52 IST,2018-03-23,20:27:52,+0530,873399943,jacobplieth,Jacob Plieth,,Final ICER report on CAR-T pricing:  https://t.co/sD6PLX4h5H $NVS $CELG $GILD,en,[],['https://icer-review.org/wp-content/uploads/2017/07/ICER_CAR_T_Final_Evidence_Report_032318.pdf'],[],0,4,7,[],"['nvs', 'celg', 'gild']",https://twitter.com/JacobPlieth/status/977197746112299008,False,,0,,,,,,,,[],,,,
976966459695030272,976966459695030272,2018-03-23 05:08:49 IST,2018-03-23,05:08:49,+0530,102754598,johncendpts,John Carroll,,"New! Poised for an FDA pitch, Novartis lays out all its PhIII cards on MS drug siponimod $NVS $CELG etc  https://t.co/Bm5rYK1V2e",en,[],['https://endpts.com/poised-for-an-fda-pitch-novartis-lays-out-all-its-phiii-cards-on-ms-drug-siponimod/'],[],2,2,11,[],"['nvs', 'celg']",https://twitter.com/JohnCendpts/status/976966459695030272,False,,0,,,,,,,,[],,,,
976444281727709186,976444281727709186,2018-03-21 18:33:52 IST,2018-03-21,18:33:52,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"A doctor speaks, a biotech stock tanks. What happened at this invite-only health care investor conference? $BLUE $CELG  https://t.co/m3oK0rTIki",en,[],['https://www.statnews.com/2018/03/21/bluebird-biotech-boston/'],[],3,10,16,[],"['blue', 'celg']",https://twitter.com/adamfeuerstein/status/976444281727709186,False,,0,,,,,,,,[],,,,
976408379672465408,976408379672465408,2018-03-21 16:11:13 IST,2018-03-21,16:11:13,+0530,102754598,johncendpts,John Carroll,,"From the PM bureau -- $CELG dives into Alzheimer's: Celgene goes all-out on neurodegeneration and Alzheimer‚Äôs, triggering blockbuster deal with $150M in cash for Prothena  https://t.co/HaRBIRCpsS",en,[],['https://endpts.com/celgene-goes-all-out-on-neurodegeneration-and-alzheimers-triggering-blockbuster-deal-with-150m-in-cash-for-prothena/'],[],2,7,10,[],['celg'],https://twitter.com/JohnCendpts/status/976408379672465408,False,,0,,,,,,,,[],,,,
976200537241681920,976200537241681920,2018-03-21 02:25:19 IST,2018-03-21,02:25:19,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$CELG $PRTA thing reminds of 2008, when Lundbeck forked over $100M to Myriad Genetics for EU rights to Alzheimer‚Äôs drug Flurizan. One month later, Flurizan failed ph3 study.",en,[],[],[],2,1,9,[],"['celg', 'prta']",https://twitter.com/adamfeuerstein/status/976200537241681920,False,,0,,,,,,,,[],,,,
976197025082630144,976197025082630144,2018-03-21 02:11:22 IST,2018-03-21,02:11:22,+0530,873399943,jacobplieth,Jacob Plieth,,I think we can honestly say we‚Äôve now reached peak Celgene. $CELG $PRTA,en,[],[],[],4,1,10,[],"['celg', 'prta']",https://twitter.com/JacobPlieth/status/976197025082630144,False,,0,,,,,,,,[],,,,
976191070139830273,976191070139830273,2018-03-21 01:47:42 IST,2018-03-21,01:47:42,+0530,102094857,adamfeuerstein,Adam Feuerstein,,How desperate is $CELG these days? Congrats to $PRTA for taking advantage of them.,en,[],[],[],7,3,28,[],"['celg', 'prta']",https://twitter.com/adamfeuerstein/status/976191070139830273,False,,0,,,,,,,,[],,,,
976189117728985089,976189117728985089,2018-03-21 01:39:57 IST,2018-03-21,01:39:57,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$CELG should have acquired Alzheon before the IPO.,en,[],[],[],3,0,8,[],['celg'],https://twitter.com/adamfeuerstein/status/976189117728985089,False,,0,,,,,,,,[],,,,
976187949703401474,976187949703401474,2018-03-21 01:35:18 IST,2018-03-21,01:35:18,+0530,102754598,johncendpts,John Carroll,,"Celgene goes all-out on neurodegeneration and Alzheimer‚Äôs, triggering blockbuster deal with $150M in cash for Prothena $CELG $PRTA   https://t.co/HaRBIRCpsS",en,[],['https://endpts.com/celgene-goes-all-out-on-neurodegeneration-and-alzheimers-triggering-blockbuster-deal-with-150m-in-cash-for-prothena/'],[],2,43,35,[],"['celg', 'prta']",https://twitter.com/JohnCendpts/status/976187949703401474,False,,0,,,,,,,,[],,,,
